<!--The following is the downloaded HTML source of the parexel.com privacy policy that was archived on 2016-06-16.
 Please check the original snapshot on the Wayback Machine (https://web.archive.org/web/20160616164002id_/https%3A//www.parexel.com/company/privacy-policy) for the most accurate reproduction.-->

<!DOCTYPE html><html lang="en" class="js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><head>
		
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<title>Privacy Policy | PAREXEL</title>
<meta name="description" content="PAREXEL will collect information through its websites that can identify you (if provided by you), such as your name, address, phone number, e-mail address, company name and position.
">

<script type="text/javascript" id="www-widgetapi-script" src="https://web.archive.org/web/20160405023908/https://s.ytimg.com/yts/jsbin/www-widgetapi-vflQQmM0D/www-widgetapi.js" async=""></script><script type="text/javascript" async="" src="//img.en25.com/i/elqCfg.min.js"></script><script src="https://web.archive.org/web/20160405024420/https://www.youtube.com/player_api"></script><script id="facebook-jssdk" src="//connect.facebook.net/en_US/sdk.js"></script><script type="text/javascript" src="//www.bugherd.com/sidebarv2.js?apikey=vvxkyoxsp6w5fkt8hpwloa"></script><script async="" src="//www.google-analytics.com/analytics.js"></script><script type="text/javascript">
var CCM_DISPATCHER_FILENAME = '/index.php';
var CCM_CID = 185;
var CCM_EDIT_MODE = false;
var CCM_ARRANGE_MODE = false;
var CCM_IMAGE_PATH = "/updates/concrete5.6.3.4/concrete/images";
var CCM_TOOLS_PATH = "/index.php/tools/required";
var CCM_BASE_URL = "https://www.parexel.com";
var CCM_REL = "";

</script>

<link rel="stylesheet" type="text/css" href="/updates/concrete5.6.3.4/concrete/css/ccm.base.css">
<script type="text/javascript" src="/updates/concrete5.6.3.4/concrete/js/jquery.js"></script>
<script type="text/javascript" src="/updates/concrete5.6.3.4/concrete/js/ccm.base.js"></script>
<link rel="stylesheet" type="text/css" href="/blocks/page_list/view.css">
<link rel="stylesheet" type="text/css" href="/packages/jereme_tweetcrete/blocks/jereme_tweetcrete/view.css">
<link rel="stylesheet" type="text/css" href="/blocks/search/templates/blog_search/view.css">
<link rel="stylesheet" type="text/css" href="/blocks/guestbook/templates/pxl_blog/view.css">
<!-- responsive -->
<script>

  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-2179840-1', 'parexel.com');
  ga('send', 'pageview');

</script>

<script type="text/javascript">
var _elqQ = _elqQ || []; _elqQ.push(['elqSetSiteId', '1959847962']); _elqQ.push(['elqTrackPageView']);
    (function () {
        function async_load() {
var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true; s.src = '//img.en25.com/i/elqCfg.min.js';
var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
}
if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
else if (window.attachEvent) window.attachEvent('onload', async_load); })();
</script>		<meta name="viewport" content="width=device-width, maximum-scale=1.0, minimum-scale=1.0, initial-scale=1.0">
		<!-- for youtube site verification -->
		<meta name="google-site-verification" content="hTgDLJeCtuQWUuYjffW3G4tCC0YyNWznN8gqT159wz0">
		<!-- OG TAGS -->
					<meta property="og:image" id="facebook-img" content="/themes/parexel-responsive/images/pxl_logo.png">
				<meta property="og:title" content="Privacy Policy">
		<meta property="og:description" content="">
		<!-- ICONS -->
		<link rel="shortcut icon" href="/themes/parexel/images/favicon.ico" type="image/x-icon">
		<link rel="icon" href="/themes/parexel/images/favicon.ico" type="image/x-icon">
		<!-- FONTS -->
		<link type="text/css" rel="stylesheet" href="https://fast.fonts.net/cssapi/57406aa1-6bd3-4571-9c29-43c56bd521fe.css">
		<!-- STYLESHEETS -->
	    <link rel="stylesheet" media="screen" type="text/css" href="/themes/parexel-responsive/styles/css/main.css">
		<link rel="stylesheet" media="screen" type="text/css" href="/themes/parexel-responsive/styles/css/media_query.css">
		<link rel="stylesheet" media="screen" type="text/css" href="/themes/parexel-responsive/styles/css/colorbox.css">
		<link rel="stylesheet" href="/remodal/dist/remodal.css">
		<link rel="stylesheet" href="/remodal/dist/remodal-default-theme.css">
	    <link rel="stylesheet" href="/fancybox/jquery.fancybox.css">


	    <!-- BUGHERD -->
	    <script type="text/javascript">
	    (function (d, t) {
	      var bh = d.createElement(t), s = d.getElementsByTagName(t)[0];
	      bh.type = 'text/javascript';
	      bh.src = '//www.bugherd.com/sidebarv2.js?apikey=vvxkyoxsp6w5fkt8hpwloa';
	      s.parentNode.insertBefore(bh, s);
	      })(document, 'script');
	    </script>

	    
	<style type="text/css">.fancybox-margin{margin-right:0px;}</style></head>
<body class="template_full_responsive page-privacy-policy default">
	
	<div id="fb-root"></div>
    <!-- parexel FB app -->
	<script>
	  window.fbAsyncInit = function() {
	    FB.init({
	      appId      : '753479204795700',
	      xfbml      : true,
	      version    : 'v2.5'
	    });
	  };
	  (function(d, s, id){
	     var js, fjs = d.getElementsByTagName(s)[0];
	     if (d.getElementById(id)) {return;}
	     js = d.createElement(s); js.id = id;
	     js.src = "//connect.facebook.net/en_US/sdk.js";
	     fjs.parentNode.insertBefore(js, fjs);
	   }(document, 'script', 'facebook-jssdk'));
	</script>

	<div id="page" class="page-privacy-policy remodal-bg remodal-is-closed">
		<!-- mega menu JS found in media-query.js -->
<nav id="mega-menu">
	<div class="close-bar">
		<div class="menu-back nav-level-top"><p>MAIN MENU</p></div>
		<div class="menu-back nav-level-one"><p>BACK</p></div>
		<div class="menu-back nav-level-two"><p>BACK</p></div>
		<div id="close-mega-menu"></div>
	</div>

		<div class="container searcher">
			<form action="/search-results/" method="get" class="ccm-search-block-form" id="nav_search">
				<input name="search_paths[]" type="hidden" value="">
				<input name="query" type="text" class="ccm-search-block-text" placeholder="SEARCH">
				<input name="submit" type="submit" value="Search" class="ccm-search-block-submit">
			</form>								
		</div>
		<div class="left">
			<nav id="utility-nav-mobile" class="mobile">
				<div class="container">
					<ul class="home-ul">
						<li class="alpha omega"><a title="Home" href="/"><div class="square home"></div>Home</a></li>
					</ul>
				</div>
				<hr>
				<div class="container">
					<ul class="main">
						<li class="alpha"><a title="Company" href="/company/"><div class="square about"></div>About</a></li>
						<li><a title="News &amp; Events" href="/company/news-events/"><div class="square news_events"></div>News &amp; Events</a></li>
						<li><a title="Investors" href="http://investor.parexel.com/"><div class="square investors"></div>Investors</a></li>
						<li><a title="Careers" href="/company/careers/"><div class="square careers"></div>Careers</a></li>
						<li><a title="Find an Office" href="/company/locations-and-offices/"><div class="square countries"></div>Countries</a></li>
						<li><a title="Contact Us" href="/company/contact/"><div class="square contact_us"></div>Contact Us</a></li>
						<li><a title="Volunteer" href="/company/volunteer/"><div class="square volunteer"></div>Volunteer</a></li>
						<li class="omega"><a title="Client Login" href="/client-login/"><div class="square login"></div>Client Login</a></li>
					</ul>
					<div class="clear"></div>
				</div>
			</nav>
			<div class="explore">Explore PAREXEL</div>
			
			<ul class="social_media">
				<li class="twitter alpha"><a href="https://twitter.com/PAREXEL" target="_blank"><span></span></a></li>
				<li class="linkedin"><a href="https://www.linkedin.com/company/parexel" target="_blank"><span></span></a></li>
				<li class="facebook"><a href="https://www.facebook.com/Parexel" target="_blank"><span></span></a></li>
				<li class="youtube omega"><a href="https://www.youtube.com/user/PAREXELInternational" target="_blank"><span></span></a></li>
			</ul>
		</div>

		

		<div class="right container">
			<div class="clear"></div>
			<div id="top-level">
				<ul class="nav">
					<li class="journey alpha"><span class="link-bucket journey" data-id="journey" data-bg="#4a2563" data-color="#4a2563">Journey</span><a href="/journey/" target="_self" class="landing-link">GO</a><span class="tick-mark"></span></li>
					<li class="solutions"><span class="link-bucket solutions" data-id="solutions" data-bg="#701538" data-color="#701538">Solutions</span><a href="/solutions/" target="_self" class="landing-link">GO</a><span class="tick-mark"></span></li>
					<li class="experience omega"><span class="link-bucket experience" data-id="experience" data-bg="#a51637" data-color="#a51637">Experience</span><a href="/experience/" target="_self" class="landing-link">GO</a><span class="tick-mark"></span></li>
					<div class="clear"></div>
				</ul>
			</div>

			<div class="second-level journey">
				<ul class="nav"><li class="alpha"><a href="/journey/planning/" target="_self" class="">Planning</a></li><li class=""><a href="/journey/phase-i/" target="_self" class="">Phase I</a></li><li class=""><a href="/journey/phase-iia/" target="_self" class="">Phase IIa</a></li><li class=""><a href="/journey/phase-ii-iii/" target="_self" class="">Phase II-III</a></li><li class=""><a href="/journey/phase-iiib-iv/" target="_self" class="">Phase IIIb-IV</a></li><li class="omega"><a href="/journey/post-launch/" target="_self" class="">Post Launch</a></li></ul>			</div>
			<div class="second-level solutions">
				<ul class="nav"><li class="alpha"><a href="/solutions/clinical-research/" target="_self" class="">Clinical Research</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/" target="_self" class="">Early Phase Services</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/dedicated-therapeutic-expertise/" target="_self" class="">Dedicated Therapeutic Expertise</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/early-phase-services/dedicated-therapeutic-expertise/early-phase-and-late-phase-integrated-study-management/" target="_self" class="">Early Phase and Late Phase integrated study management</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/patient-populations/" target="_self" class="">Patient Populations</a></li><li class=""><a href="/solutions/clinical-research/early-phase-services/strategic-locations/" target="_self" class="">Strategic Locations</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/berlin/" target="_self" class="">Berlin</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/berlin/virtual-tour/" target="_self" class="">Virtual Tour</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/strategic-locations/london/" target="_self" class="">London</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/london/virtual-tour/" target="_self" class="">Virtual Tour</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/strategic-locations/baltimore/" target="_self" class="">Baltimore</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/baltimore/facility/" target="_self" class="">Facility</a></li><li class="omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/baltimore/virtual-tour/" target="_self" class="">Virtual Tour</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/strategic-locations/los-angeles/" target="_self" class="">Los Angeles</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/los-angeles/virtual-tour/" target="_self" class="">Virtual Tour</a></li></ul></li><li class="omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/bloemfontein/" target="_self" class="">Bloemfontein</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/bloemfontein/facility/" target="_self" class="">Facility</a></li><li class="omega"><a href="/solutions/clinical-research/early-phase-services/strategic-locations/bloemfontein/virtual-tour/" target="_self" class="">Virtual Tour</a></li></ul></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/phase-1-first-human/" target="_self" class="">Phase 1, First in Human</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/early-phase-services/phase-1-first-human/ethno-bridging-accelerated-global-drug-development/" target="_self" class="">Ethnobridging for Accelerated Global Drug Development</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/phase-iia-proof-concept/" target="_self" class="">Phase IIa, Proof of Concept</a></li><li class=""><a href="/solutions/clinical-research/early-phase-services/early-product-development/" target="_self" class="">Early Product Development</a></li><li class=""><a href="/solutions/clinical-research/early-phase-services/ethnobridging/" target="_self" class="">Ethnobridging</a></li><li class=""><a href="/solutions/clinical-research/early-phase-services/clinical-pkpd-and-pharmacometrics-services/" target="_self" class="">Clinical PK/PD and Pharmacometrics Services</a><ul><li class="alpha"><a href="/solutions/clinical-research/early-phase-services/clinical-pkpd-and-pharmacometrics-services/case-study-safetypharmacovigilance-1/" target="_self" class="">Case Study: Safety/Pharmacovigilance #1</a></li><li class="omega"><a href="/solutions/clinical-research/early-phase-services/clinical-pkpd-and-pharmacometrics-services/case-study-safetypharmacovigilance-2/" target="_self" class="">Case Study: Safety/Pharmacovigilance #2</a></li></ul></li><li class=""><a href="/solutions/clinical-research/early-phase-services/bioanalytical-and-biomarker-services/" target="_self" class="">Bioanalytical and Biomarkers</a></li><li class=""><a href="/solutions/clinical-research/early-phase-services/bioequivalence-services/" target="_self" class="">Bioequivalence Studies</a></li><li class="omega"><a href="/solutions/clinical-research/early-phase-services/volunteer/" target="_self" class="">Volunteer to Participate</a></li></ul></li><li class=""><a href="/solutions/clinical-research/phase-ii-iii/" target="_self" class="">Phase II-III Services</a><ul><li class="alpha"><a href="/solutions/clinical-research/phase-ii-iii/phase-iii/" target="_self" class="">Phase III</a><ul><li class="alpha"><a href="/solutions/clinical-research/phase-ii-iii/phase-iii/case-study-chronic-renal-failure/" target="_self" class="">Case Study: Chronic Renal Failure</a></li><li class=""><a href="/solutions/clinical-research/phase-ii-iii/phase-iii/case-study-expanded-access-program/" target="_self" class="">Case Study: Expanded Access Program</a></li><li class="omega"><a href="/solutions/clinical-research/phase-ii-iii/phase-iii/case-study-accelerating-development-global-copd-trials/" target="_self" class="">Case Study: Accelerating development in global COPD trials</a></li></ul></li><li class=""><a href="/solutions/clinical-research/phase-ii-iii/medical-writing-and-submission/" target="_self" class="">Medical Writing and Submission</a></li><li class="omega"><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/" target="_self" class="">Feasibility and Enrollment</a><ul><li class="alpha"><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/patient-recruitment/" target="_self" class="">Patient Recruitment</a><ul><li class="alpha omega"><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/patient-recruitment/case-study-pediatric-migraine-patient-recruitment/" target="_self" class="">Case Study: Pediatric Migraine Patient Recruitment</a></li></ul></li><li class=""><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/country-site-selection/" target="_self" class="">Country and Site Selection</a></li><li class=""><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/site-strategy/" target="_self" class="">Alliance Site Strategy</a></li><li class="omega"><a href="/solutions/clinical-research/phase-ii-iii/feasibility-enrollment/protocol-optimization/" target="_self" class="">Protocol Optimization</a></li></ul></li></ul></li><li class=""><a href="/solutions/clinical-research/phase-iiib-iv/" target="_self" class="">Phase IIIb-IV</a></li><li class=""><a href="/solutions/clinical-research/quantitative-clinical-development/" target="_self" class="">Quantitative Clinical Development Services</a></li><li class=""><a href="/solutions/clinical-research/clinical-development-optimization/" target="_self" class="">Clinical Development Optimization</a><ul><li class="alpha"><a href="/solutions/clinical-research/clinical-development-optimization/data-surveillance/" target="_self" class="">Data Surveillance</a></li><li class=""><a href="/solutions/clinical-research/clinical-development-optimization/site-regulatory-documentation/" target="_self" class="">Site Regulatory Documentation</a></li><li class="omega"><a href="/solutions/clinical-research/clinical-development-optimization/critical-path-management/" target="_self" class="">Critical Path Management</a></li></ul></li><li class=""><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/" target="_self" class="">Clinical Trial Supplies &amp; Logistics</a><ul><li class="alpha"><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/global-reach/" target="_self" class="">Global Reach</a></li><li class=""><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/clinical-trial-supplies/" target="_self" class="">Clinical Trial Supplies</a></li><li class=""><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/ancillary-supplies/" target="_self" class="">Ancillary Supplies</a></li><li class=""><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/lab-logistics/" target="_self" class="">Laboratory Logistics Services</a></li><li class="omega"><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/r/" target="_self" class="">Randomization and Trial Supply Management</a></li></ul></li><li class=""><a href="/solutions/clinical-research/customer-care/" target="_self" class="">Customer Care Services</a></li><li class="omega"><a href="/solutions/clinical-research/genomic-medicine-services/" target="_self" class="">Genomic Medicine Services</a></li></ul></li><li class=""><a href="/solutions/informatics/" target="_self" class="">Informatics</a><ul><li class="alpha"><a href="/solutions/informatics/perceptive-mytrials/" target="_self" class="">Perceptive MyTrials®</a><ul><li class="alpha"><a href="/solutions/informatics/datadrivenmonitoring/" target="_self" class="">Data-Driven Monitoring</a></li><li class=""><a href="/solutions/informatics/perceptive-mytrials/combined-edc-rtsm/" target="_self" class="">Combined EDC-RTSM</a></li><li class=""><a href="/solutions/informatics/perceptive-mytrials/eclinical-metrics/" target="_self" class="">eClinical Metrics</a></li><li class=""><a href="/solutions/informatics/perceptive-mytrials/collaboration-toolbox/" target="_self" class="">Collaboration Toolbox</a></li><li class=""><a href="/solutions/informatics/perceptive-mytrials/integration-services/" target="_self" class="">Integration Services</a></li><li class=""><a href="/solutions/informatics/perceptive-mytrials/mytrials-platform-and-infrastructure/" target="_self" class="">Perceptive MyTrials® Platform and Infrastructure</a></li><li class="omega"><a href="/solutions/informatics/perceptive-mytrials/perceptive-mytrialsanalytics/" target="_self" class="">Perceptive MyTrials® Analytics</a></li></ul></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/" target="_self" class="">Study Management and Monitoring</a><ul><li class="alpha"><a href="/solutions/informatics/ctms-clinical-trial-software/impact-ctms-software/" target="_self" class="">IMPACT® CTMS Software</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-ctms-support/" target="_self" class="">IMPACT® CTMS Support</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-progress/" target="_self" class="">IMPACT® Progress</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-mysites/" target="_self" class="">IMPACT® MySites</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-investigator/" target="_self" class="">IMPACT® Investigator</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-clinical-cost-tracking/" target="_self" class="">IMPACT® Clinical Cost Tracking</a></li><li class=""><a href="/solutions/informatics/ctms-clinical-trial-software/impact-clinical-supplies-tracking/" target="_self" class="">IMPACT® Clinical Supplies Tracking</a></li><li class="omega"><a href="/solutions/informatics/ctms-clinical-trial-software/risk-based-monitoring/" target="_self" class="">Risk-Based Monitoring</a><ul><li class="alpha omega"><a href="http://www.clinicalleader.com/doc/risk-based-monitoring-keeping-clinical-trials-a-human-endeavor-0001" target="_blank" class="">Clinical Leader Interview with Camie Briton</a></li></ul></li></ul></li><li class=""><a href="/solutions/informatics/clinical-data-management/" target="_self" class="">Clinical Data Management</a><ul><li class="alpha"><a href="/solutions/informatics/clinical-data-management/datalabs-edc/" target="_self" class="">DataLabs® EDC</a><ul><li class="alpha"><a href="/solutions/informatics/clinical-data-management/datalabs-edc/edc-ranked-highest-customer-satisfaction/" target="_self" class="">EDC ranked highest in customer satisfaction</a></li><li class="omega"><a href="/solutions/informatics/clinical-data-management/datalabs-edc/taking-pain-out-edc-deployment/" target="_self" class="">Taking the Pain out of EDC Deployment</a></li></ul></li><li class=""><a href="/solutions/informatics/clinical-data-management/clinical-adjudication/" target="_self" class="">Clinical Adjudication</a></li><li class=""><a href="/solutions/informatics/clinical-data-management/adaptive-trials/" target="_self" class="">Adaptive Trials</a></li><li class="omega"><a href="https://www.parexel.com/files/3413/9662/1123/EDC_Brochure_-_Mar_14.pdf" target="_blank" class="">EDC Datasheet</a></li></ul></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/" target="_self" class="">Randomization and Trial Supply Management</a><ul><li class="alpha"><a href="/solutions/informatics/randomization-and-trial-supply-management/early-phase/" target="_self" class="">ClinPhone® RTSM for Early Phase</a></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/phaseii-iii/" target="_self" class="">ClinPhone® RTSM for Phase II/III</a><ul><li class="alpha"><a href="/solutions/informatics/randomization-and-trial-supply-management/phaseii-iii/faster-rtsm/" target="_self" class="">Faster implementation of RTSM (a.k.a. IRT) systems</a></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/phaseii-iii/clinphone-accountability/" target="_self" class="">Drug Accountability</a></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/phaseii-iii/adaptive-trials/" target="_self" class="">Adaptive Trials</a></li><li class="omega"><a href="/solutions/informatics/randomization-and-trial-supply-management/phaseii-iii/reporting-solutions/" target="_self" class="">Reporting Solutions</a></li></ul></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/peri-post-approval/" target="_self" class="">ClinPhone® RTSM for Peri/Post-Approval</a></li><li class=""><a href="/solutions/informatics/randomization-and-trial-supply-management/asia-pacific/" target="_self" class="">ClinPhone® RTSM for Asia-Pacific</a></li><li class="omega"><a href="/solutions/informatics/randomization-and-trial-supply-management/c/" target="_self" class="">Clinical Trial Supplies &amp; Logistics</a></li></ul></li><li class=""><a href="/solutions/informatics/spirometry/" target="_self" class="">Pulmonary Function Testing</a></li><li class=""><a href="/solutions/informatics/medical-imaging/" target="_self" class="">Medical Imaging</a><ul><li class="alpha"><a href="/solutions/informatics/medical-imaging/expertise/" target="_self" class="">Therapeutic Expertise</a><ul><li class="alpha"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/" target="_self" class="">Oncology Imaging Expertise</a><ul><li class="alpha omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/" target="_self" class="">Criteria Experience</a><ul><li class="alpha"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/1996-nci-wg-cll/" target="_self" class="">1996 NCI-WG CLL</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/" target="_self" class="">IWCLL 2008</a><ul><li class="alpha omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/" target="_self" class="">Key Topics: IWCLL 2008</a><ul><li class="alpha"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/1/" target="_self" class="">Definitions</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/2/" target="_self" class="">Usable Criteria to Evaluate</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/3/" target="_self" class="">Target Sites of Disease</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/4/" target="_self" class="">Non-Target Sites of Disease</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/5/" target="_self" class="">Organomegaly</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/6/" target="_self" class="">New Lesions</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/7/" target="_self" class="">B symptoms</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/8/" target="_self" class="">Blood Counts</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/9/" target="_self" class="">Bone Marrow</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/10/" target="_self" class="">Transformation</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/11/" target="_self" class="">Role of Imaging in CLL Clinical Trials</a></li><li class="omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/iwcll-2008/key-topics/12/" target="_self" class="">Clinical Data Assessments</a></li></ul></li></ul></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/1999-iwg-nhl/" target="_self" class="">1999 IWG-NHL</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/" target="_self" class="">2007 IWG-NHL</a><ul><li class="alpha omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/" target="_self" class="">Key Topics: 2007 IWG-NHL Assessment Criteria</a><ul><li class="alpha"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/1/" target="_self" class="">Definitions</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/2/" target="_self" class="">Usable Criteria to Evaluate</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/3/" target="_self" class="">Target Sites of Disease</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/4/" target="_self" class="">Non-Target Sites of Disease</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/5/" target="_self" class="">Organomegaly</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/6/" target="_self" class="">New Lesions</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/7/" target="_self" class="">Bone Marrow</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/8/" target="_self" class="">Other Laboratory Values and Symptoms</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/9/" target="_self" class="">Incorporation of FDG-PET</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/10/" target="_self" class="">Defining Normal, Abnormal and Measurable</a></li><li class="omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-oncology/criteria-expertise/2007-iwg-nhl/key-topics/11/" target="_self" class="">Problem with CRu</a></li></ul></li></ul></li><li class="omega"><a href="http://www.recist.com/" target="_self" class="">RECIST</a></li></ul></li></ul></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/respiratory-pulmonology/" target="_self" class="">Respiratory and Pulmonology Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/ophthalmology/" target="_self" class="">Ophthalmology Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/gastroenterology/" target="_self" class="">Gastroenterology Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/dermatology/" target="_self" class="">Dermatology Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/womens-health/" target="_self" class="">Women's Health Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/msk/" target="_self" class="">Musculoskeletal (MSK)  Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/imaging-cns/" target="_self" class="">Neurology Imaging Expertise</a></li><li class=""><a href="/solutions/informatics/medical-imaging/expertise/volumetric/" target="_self" class="">Volumetric Imaging Expertise</a></li><li class="omega"><a href="/solutions/informatics/medical-imaging/expertise/imaging-cardio/" target="_self" class="">Cardiovascular Imaging Expertise</a></li></ul></li><li class=""><a href="/solutions/informatics/medical-imaging/imaging-services/" target="_self" class="">Imaging Services</a></li><li class=""><a href="/solutions/informatics/medical-imaging/scientific-advisors/" target="_self" class="">Scientific Advisors</a></li><li class=""><a href="/solutions/informatics/medical-imaging/consultation/" target="_self" class="">Consultation</a></li><li class="omega"><a href="/solutions/informatics/medical-imaging/advanced-medical-imaging/" target="_self" class="">Advanced Medical Imaging</a><ul><li class="alpha omega"><a href="/solutions/informatics/medical-imaging/advanced-medical-imaging/happy-sites/" target="_self" class="">Cloud-Based Solutions for Sites</a></li></ul></li></ul></li><li class=""><a href="/solutions/informatics/regulatory-information-management/" target="_self" class="">Regulatory Information Management</a><ul><li class="alpha"><a href="/solutions/informatics/regulatory-information-management/insight-product-service/" target="_self" class="">LIQUENT InSight®</a></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-smartdesk/" target="_self" class="">LIQUENT® SmartDesk</a></li><li class=""><a href="/solutions/informatics/regulatory-information-management/regulatory-cloud/" target="_self" class="">Regulatory Cloud</a></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/" target="_self" class="">LIQUENT® Educational Services</a><ul><li class="alpha"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/about-training/" target="_self" class="">About Training</a></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/types-training/" target="_self" class="">Types of Training</a></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/" target="_self" class="">Courses &amp; Registration</a><ul><li class="alpha"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-insight-submission-management/" target="_self" class="">LIQUENT InSight® for Submission Management</a><ul><li class="alpha omega"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-insight-submission-management/liquent-insightsubmission-planning-and-tracking/" target="_self" class="">LIQUENT InSight®Submission Planning and Tracking</a></li></ul></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-smartdesk/" target="_self" class="">LIQUENT SmartDesk™</a><ul><li class="alpha omega"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-smartdesk/automating-publishing-process-liquent-smartdesk-pdf/" target="_self" class="">Automating the Publishing Process with LIQUENT SmartDesk™ for PDF</a></li></ul></li><li class="omega"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-insight-viewing/" target="_self" class="">LIQUENT InSight for Viewing</a><ul><li class="alpha omega"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/courses-registration/liquent-insight-viewing/reviewing-submissions-liquent-insight-viewing/" target="_self" class="">Reviewing Submissions with LIQUENT InSight® for Viewing</a></li></ul></li></ul></li><li class=""><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/training-resources/" target="_self" class="">Training Resources</a></li><li class="omega"><a href="/solutions/informatics/regulatory-information-management/liquent-educational-services/certification/" target="_self" class="">Certification</a></li></ul></li><li class="omega"><a href="/solutions/informatics/regulatory-information-management/regulatory-outsourcing-services/" target="_self" class="">Regulatory Outsourcing Services</a></li></ul></li><li class=""><a href="/solutions/informatics/customer-care/" target="_self" class="">Customer Care Services</a></li><li class=""><a href="/solutions/informatics/perceptive-institute/" target="_self" class="">Perceptive® Institute Training</a><ul><li class="alpha"><a href="/solutions/informatics/perceptive-institute/edc-training/" target="_self" class="">DataLabs® EDC Training</a></li><li class=""><a href="/solutions/informatics/perceptive-institute/mytrials-training/" target="_self" class="">Perceptive MyTrials® Training</a></li><li class=""><a href="/solutions/informatics/perceptive-institute/data-driven-monitoring-training/" target="_self" class="">Data-Driven Monitoring Training</a></li><li class=""><a href="/solutions/informatics/perceptive-institute/certification/" target="_self" class="">Certification Programs</a></li><li class=""><a href="/solutions/informatics/perceptive-institute/impact-ctms-training/" target="_self" class="">IMPACT® CTMS Training</a></li><li class="omega"><a href="/solutions/informatics/perceptive-institute/other-training-services/" target="_self" class="">Other Training Services</a></li></ul></li><li class="omega"><a href="/solutions/informatics/clinical-outcome-assessments/" target="_self" class="">Electronic Clinical Outcome Assessments (eCOA)</a><ul><li class="alpha"><a href="/solutions/informatics/clinical-outcome-assessments/epro/" target="_self" class="">ePRO (electronic Patient Reported Outcomes)</a></li><li class="omega"><a href="/solutions/informatics/clinical-outcome-assessments/coa-consulting/" target="_self" class="">Clinical Outcome Assessments Consulting</a></li></ul></li></ul></li><li class=""><a href="/solutions/consulting/" target="_self" class="">Consulting</a><ul><li class="alpha"><a href="/solutions/consulting/integrated-product-development/" target="_self" class="">Integrated Product Development</a><ul><li class="alpha omega"><a href="/solutions/consulting/integrated-product-development/biosimilar-milestone-implications-neupogen/" target="_self" class="">A Biosimilar Milestone with Implications</a></li></ul></li><li class=""><a href="/solutions/consulting/strategic-compliance-risk-management/" target="_self" class="">Regulatory Compliance &amp; Risk Management</a><ul><li class="alpha"><a href="/solutions/consulting/strategic-compliance-risk-management/qa-about-gcp/" target="_self" class="">Q&amp;A about GCP</a><ul><li class="alpha omega"><a href="/solutions/consulting/strategic-compliance-risk-management/qa-about-gcp/quality-design-putting-theory-practice/" target="_self" class="">Quality By Design Putting Theory Into Practice</a></li></ul></li><li class=""><a href="/solutions/consulting/strategic-compliance-risk-management/strategic-compliance-data-integrity/" target="_self" class="">Strategic Compliance: Data Integrity</a></li><li class=""><a href="/solutions/consulting/strategic-compliance-risk-management/fda-483-observations/" target="_self" class="">FDA 483s: Your Questions Answered</a></li><li class=""><a href="/solutions/consulting/strategic-compliance-risk-management/important-reminder/" target="_self" class="">Important Reminder About PET (Positron Emitting Topography) FDA Regulations</a></li><li class="omega"><a href="/solutions/consulting/strategic-compliance-risk-management/quality-design-putting-theory-practice/" target="_self" class="">Quality By Design Putting Theory Into Practice</a></li></ul></li><li class=""><a href="/solutions/consulting/regulatory-outsourcing-services/" target="_self" class="">Regulatory Outsourcing</a><ul><li class="alpha omega"><a href="/solutions/consulting/regulatory-outsourcing-services/ectd/" target="_self" class="">eCTD</a></li></ul></li><li class=""><a href="/solutions/consulting/idmp-solutions/" target="_self" class="">Regulatory Information Management &amp; IDMP Solutions</a><ul><li class="alpha"><a href="/solutions/consulting/idmp-solutions/idmp-readiness-assessment/" target="_self" class="">IDMP Readiness Assessment</a></li><li class="omega"><a href="/solutions/consulting/idmp-solutions/idmp-task-force-updates/" target="_self" class="">IDMP Task Force Updates</a><ul><li class="alpha omega"><a href="/solutions/consulting/idmp-solutions/idmp-task-force-updates/november-2015-task-force-meeting/" target="_self" class="">November 2015 Task Force Meeting</a></li></ul></li></ul></li><li class="omega"><a href="/solutions/consulting/customer-care/" target="_self" class="">Customer Care Services</a></li></ul></li><li class="omega"><a href="/solutions/access/" target="_self" class="">Access</a><ul><li class="alpha"><a href="/solutions/access/late-stage-clinical-operations/" target="_self" class="">Late-Stage Clinical Operations</a><ul><li class="alpha"><a href="/solutions/access/late-stage-clinical-operations/late-phase-interventional-trials/" target="_self" class="">Late Phase Interventional Trials</a></li><li class=""><a href="/solutions/access/late-stage-clinical-operations/observational-studies/" target="_self" class="">Observational Research</a></li><li class=""><a href="/solutions/access/late-stage-clinical-operations/epidemiology/" target="_self" class="">Epidemiology</a></li><li class=""><a href="/solutions/access/late-stage-clinical-operations/expanded-access-programs/" target="_self" class="">Expanded Access Programs</a></li><li class="omega"><a href="/solutions/access/late-stage-clinical-operations/patient-reported-outcomes/" target="_self" class="">Patient-reported Outcomes</a><ul><li class="alpha"><a href="/solutions/access/late-stage-clinical-operations/patient-reported-outcomes/case-study-health-economics/" target="_self" class="">Case Study: Health Economics</a></li><li class="omega"><a href="/solutions/access/late-stage-clinical-operations/patient-reported-outcomes/outcomes-research/" target="_self" class="">Outcomes Research</a></li></ul></li></ul></li><li class=""><a href="/solutions/access/market-access-consulting/" target="_self" class="">Market Access Consulting</a><ul><li class="alpha"><a href="/solutions/access/market-access-consulting/commercial-decision-pathways/" target="_self" class="">Commercial Decision Pathways</a></li><li class=""><a href="/solutions/access/market-access-consulting/evidence-generation/" target="_self" class="">Evidence Generation</a><ul><li class="alpha"><a href="/solutions/access/market-access-consulting/evidence-generation/evidence-review/" target="_self" class="">Evidence Review and Meta-Analysis</a><ul><li class="alpha"><a href="/solutions/access/market-access-consulting/evidence-generation/evidence-review/evidence-review-options/" target="_self" class="">Evidence Review Options</a></li><li class="omega"><a href="/solutions/access/market-access-consulting/evidence-generation/evidence-review/evidence-review-resources/" target="_self" class="">Evidence Review Resources</a></li></ul></li><li class=""><a href="/solutions/access/market-access-consulting/evidence-generation/health-economic-modeling/" target="_self" class="">Health Economic Modeling</a></li><li class=""><a href="/solutions/access/market-access-consulting/evidence-generation/dossiers-amcp-global/" target="_self" class="">Global and AMCP Value Dossiers</a></li><li class=""><a href="/solutions/access/market-access-consulting/evidence-generation/manuscripts-posters/" target="_self" class="">Manuscripts and Posters</a></li><li class=""><a href="/solutions/access/market-access-consulting/evidence-generation/data-analytics/" target="_self" class="">Data Analytics</a></li><li class="omega"><a href="/solutions/access/market-access-consulting/evidence-generation/strategic-communications/" target="_self" class="">Strategic Communications</a></li></ul></li><li class=""><a href="/solutions/access/market-access-consulting/access-realization/" target="_self" class="">Access Realization</a><ul><li class="alpha"><a href="/solutions/access/market-access-consulting/access-realization/market-access-strategy/" target="_self" class="">Pricing, Reimbursement and Market Access Expertise</a></li><li class="omega"><a href="/solutions/access/market-access-consulting/access-realization/global-pricing-reimbursement-and-market-access-services/" target="_self" class="">List of Services: Pricing, Reimbursement and Market Access</a></li></ul></li><li class="omega"><a href="/solutions/access/market-access-consulting/market-access-hub-services/" target="_self" class="">Market Access and HUB Services</a></li></ul></li><li class=""><a href="/solutions/access/drug-safety-services/" target="_self" class="">Drug Safety Services</a><ul><li class="alpha omega"><a href="/solutions/access/drug-safety-services/risk-management-rems/" target="_self" class="">Risk Management / REMS</a></li></ul></li><li class=""><a href="/solutions/access/qsi/" target="_self" class="">QSI</a></li><li class=""><a href="/solutions/access/medical-communications-services/" target="_self" class="">Medical Communications</a><ul><li class="alpha"><a href="/solutions/access/medical-communications-services/communications-planning-publications-programs/" target="_self" class="">Communications Planning &amp; Publications Programs</a><ul><li class="alpha"><a href="/solutions/access/medical-communications-services/communications-planning-publications-programs/patient-narratives-and-clinical-study-report-re-write-mega-trial/" target="_self" class="">Patient narratives and clinical study report re-write for mega trial</a></li><li class=""><a href="/solutions/access/medical-communications-services/communications-planning-publications-programs/scientific-writing/" target="_self" class="">Scientific Writing</a></li><li class=""><a href="/solutions/access/medical-communications-services/communications-planning-publications-programs/strategic-communications/" target="_self" class="">Strategic Communications</a></li><li class="omega"><a href="/solutions/access/medical-communications-services/communications-planning-publications-programs/publications-planning/" target="_self" class="">Publications Planning</a></li></ul></li><li class=""><a href="/solutions/access/medical-communications-services/scientific-clinical-health-economic-writing/" target="_self" class="">Scientific, Clinical &amp; Health-Economic Writing</a></li><li class=""><a href="/solutions/access/medical-communications-services/kol-advisory/" target="_self" class="">KOL Advisory</a></li><li class=""><a href="/solutions/access/medical-communications-services/branding-design/" target="_self" class="">Branding &amp; Design</a></li><li class=""><a href="/solutions/access/medical-communications-services/digital-interactive-media/" target="_self" class="">Digital Interactive Media</a></li><li class=""><a href="/solutions/access/medical-communications-services/global-meetings-events-management/" target="_self" class="">Global Meetings &amp; Events Management</a></li><li class="omega"><a href="/solutions/access/medical-communications-services/payer-communication/" target="_self" class="">Payer Communications</a></li></ul></li><li class="omega"><a href="/solutions/access/real-world-evidence/" target="_self" class="">Real-World Evidence</a><ul><li class="alpha omega"><a href="/solutions/access/real-world-evidence/real-world-data-webinar/" target="_self" class="">Real-World Data Webinar</a></li></ul></li></ul></li></ul>			</div>
			<div class="second-level experience">
				<ul class="nav"><li class="alpha"><a href="/experience/therapeutic-expertise/" target="_self" class="">Therapeutic Expertise</a><ul><li class="alpha"><a href="/experience/therapeutic-expertise/oncology-hematology/" target="_self" class="">Oncology</a></li><li class=""><a href="/experience/therapeutic-expertise/cardiovascular-metabolic-diseases/" target="_self" class="">Cardiovascular &amp; Metabolic Diseases</a></li><li class=""><a href="/experience/therapeutic-expertise/central-nervous-system-cns-disorders/" target="_self" class="">Central Nervous System (CNS) Disorders</a></li><li class=""><a href="/experience/therapeutic-expertise/infectious-diseases/" target="_self" class="">Infectious Disease</a></li><li class=""><a href="/experience/therapeutic-expertise/respiratory-capabilities/" target="_self" class="">Respiratory Capabilities</a></li><li class="omega"><a href="/experience/therapeutic-expertise/rheumatology-immunology-capabilities/" target="_self" class="">Rheumatology &amp; Immunology Capabilities</a></li></ul></li><li class=""><a href="/experience/industry-expertise/" target="_self" class="">Industry Expertise</a><ul><li class="alpha"><a href="/experience/industry-expertise/pharmaceuticals/" target="_self" class="">Pharmaceuticals</a><ul><li class="alpha omega"><a href="/experience/industry-expertise/pharmaceuticals/biosimilar-consulting/" target="_self" class="">Biosimilar Consulting</a></li></ul></li><li class=""><a href="/experience/industry-expertise/medical-devices/" target="_self" class="">Medical Devices</a></li><li class=""><a href="/experience/industry-expertise/biologics/" target="_self" class="">Biologics</a></li><li class="omega"><a href="/experience/industry-expertise/biosimilars/" target="_self" class="">Biosimilars</a><ul><li class="alpha omega"><a href="http://youtu.be/e-FM1WFMmjM" target="_blank" class="">Biosimilar Video</a></li></ul></li></ul></li><li class=""><a href="/experience/regulatory-expertise/" target="_self" class="">Regulatory Expertise</a></li><li class=""><a href="/experience/market-access-expertise/" target="_self" class="">Market Access Expertise</a></li><li class=""><a href="/experience/global-presence/" target="_self" class="">Global Presence</a><ul><li class="alpha"><a href="/experience/global-presence/north-america/" target="_self" class="">North America</a></li><li class=""><a href="/experience/global-presence/south-america/" target="_self" class="">South America</a></li><li class=""><a href="/experience/global-presence/europe/" target="_self" class="">Europe</a></li><li class=""><a href="/experience/global-presence/asia/" target="_self" class="">Asia</a></li><li class=""><a href="/experience/global-presence/middle-east-africa/" target="_self" class="">Middle East &amp; Africa</a></li><li class="omega"><a href="/experience/global-presence/emerging-markets/" target="_self" class="">Emerging Markets</a></li></ul></li><li class="omega"><a href="/experience/delivery-models/" target="_self" class="">Delivery Models</a><ul><li class="alpha"><a href="/experience/delivery-models/strategic-partnerships/" target="_self" class="">Strategic Partnerships</a><ul><li class="alpha omega"><a href="/experience/delivery-models/strategic-partnerships/essential-building-blocks-successful-strategic-partnerships/" target="_self" class="">Essential building blocks for Successful Strategic Partnerships</a></li></ul></li><li class=""><a href="/experience/delivery-models/functional-services/" target="_self" class="">Functional Services</a><ul><li class="alpha omega"><a href="/experience/delivery-models/functional-services/dedicated-your-success/" target="_self" class="">Dedicated to Your Success</a></li></ul></li><li class="omega"><a href="/experience/delivery-models/biopharm/" target="_self" class="">PAREXEL® BioPharm Unit</a></li></ul></li></ul>			</div>
			<div id="mobile-search">
			
				<ul class="social_media">
					<li class="twitter alpha"><a href="https://twitter.com/PAREXEL" target="_blank"><span></span></a></li>
					<li class="linkedin"><a href="https://www.linkedin.com/company/parexel" target="_blank"><span></span></a></li>
					<li class="facebook"><a href="https://www.facebook.com/Parexel" target="_blank"><span></span></a></li>
					<li class="youtube omega"><a href="https://www.youtube.com/user/PAREXELInternational" target="_blank"><span></span></a></li>
				</ul>
				<div class="clear"></div>
			</div>
		</div>
		<div class="clear"></div>
		
		<div class="clear"></div>
	
	
</nav>		<header>
			<nav id="utility-nav" class="desktop">
				<div class="container">
					<ul>
						<li class="alpha"><a title="Company" href="/company/">About</a></li>
						<li><a title="News &amp; Events" href="/company/news-events/">News &amp; Events</a></li>
						<li><a title="Investors" href="http://investor.parexel.com/">Investors</a></li>
						<li><a title="Careers" href="/company/careers/">Careers</a></li>
						<li><a title="Find an Office" href="/company/locations-and-offices/">Countries</a></li>
						<li><a title="Contact Us" href="/company/contact/">Contact Us</a></li>
						<li><a title="Volunteer" href="/company/volunteer/">Volunteer</a></li>
						<li class="omega"><a title="Client Login" href="/client-login/">Client Login</a></li>
					</ul>
					<div class="clear"></div>
				</div>
			</nav>
			<div id="main-nav-overflow"></div>
			<div class="container">
				<div id="main-nav-container">
						<div id="main_nav_wrap">
							<nav id="main_nav">
								<ul class="nav"><li class="show-in-secondary with_border red_bottom journey alpha"><a href="/journey/" target="_self" data-id="journey" class="show-in-secondary with_border red_bottom">Journey</a><ul class="level1"><li class="journey_sub show-in-secondary planning alpha"><a href="/journey/planning/" target="_self" data-id="planning" class="journey_sub show-in-secondary">Planning</a></li><li class="journey_sub show-in-secondary phase i"><a href="/journey/phase-i/" target="_self" data-id="phase i" class="journey_sub show-in-secondary">Phase I</a></li><li class="show-in-secondary phase iia"><a href="/journey/phase-iia/" target="_self" data-id="phase iia" class="show-in-secondary">Phase IIa</a></li><li class="show-in-secondary phase ii-iii"><a href="/journey/phase-ii-iii/" target="_self" data-id="phase ii-iii" class="show-in-secondary">Phase II-III</a></li><li class="show-in-secondary phase iiib-iv"><a href="/journey/phase-iiib-iv/" target="_self" data-id="phase iiib-iv" class="show-in-secondary">Phase IIIb-IV</a></li><li class="show-in-secondary post launch omega"><a href="/journey/post-launch/" target="_self" data-id="post launch" class="show-in-secondary">Post Launch</a></li></ul></li><li class="show-in-secondary with_border red_bottom solutions"><a href="/solutions/" target="_self" data-id="solutions" class="show-in-secondary with_border red_bottom">Solutions</a><ul class="level1"><li class="show-in-secondary clinical research alpha"><a href="/solutions/clinical-research/" target="_self" data-id="clinical research" class="show-in-secondary">Clinical Research</a><ul class="level2"><li class="show-in-secondary early phase services alpha"><a href="/solutions/clinical-research/early-phase-services/" target="_self" data-id="early phase services" class="show-in-secondary">Early Phase Services</a></li><li class="show-in-secondary phase ii-iii services"><a href="/solutions/clinical-research/phase-ii-iii/" target="_self" data-id="phase ii-iii services" class="show-in-secondary">Phase II-III Services</a></li><li class=" phase iiib-iv" style="display: none;"><a href="/solutions/clinical-research/phase-iiib-iv/" target="_self" data-id="phase iiib-iv" class="">Phase IIIb-IV</a></li><li class=" quantitative clinical development services" style="display: none;"><a href="/solutions/clinical-research/quantitative-clinical-development/" target="_self" data-id="quantitative clinical development services" class="">Quantitative Clinical Development Services</a></li><li class="show-in-secondary clinical development optimization"><a href="/solutions/clinical-research/clinical-development-optimization/" target="_self" data-id="clinical development optimization" class="show-in-secondary">Clinical Development Optimization</a></li><li class=" clinical trial supplies &amp; logistics" style="display: none;"><a href="/solutions/clinical-research/clinical-trial-supplies-and-logistics/" target="_self" data-id="clinical trial supplies &amp; logistics" class="">Clinical Trial Supplies &amp; Logistics</a></li><li class="show-in-secondary customer care services"><a href="/solutions/clinical-research/customer-care/" target="_self" data-id="customer care services" class="show-in-secondary">Customer Care Services</a></li><li class="genomic medicine services omega" style="display: none;"><a href="/solutions/clinical-research/genomic-medicine-services/" target="_self" data-id="genomic medicine services" class="">Genomic Medicine Services</a></li></ul></li><li class="show-in-secondary informatics"><a href="/solutions/informatics/" target="_self" data-id="informatics" class="show-in-secondary">Informatics</a><ul class="level2"><li class="show-in-secondary perceptive mytrials® alpha"><a href="/solutions/informatics/perceptive-mytrials/" target="_self" data-id="perceptive mytrials®" class="show-in-secondary">Perceptive MyTrials®</a></li><li class="show-in-secondary study management and monitoring"><a href="/solutions/informatics/ctms-clinical-trial-software/" target="_self" data-id="study management and monitoring" class="show-in-secondary">Study Management and Monitoring</a></li><li class="show-in-secondary clinical data management"><a href="/solutions/informatics/clinical-data-management/" target="_self" data-id="clinical data management" class="show-in-secondary">Clinical Data Management</a></li><li class="show-in-secondary randomization and trial supply management"><a href="/solutions/informatics/randomization-and-trial-supply-management/" target="_self" data-id="randomization and trial supply management" class="show-in-secondary">Randomization and Trial Supply Management</a></li><li class="show-in-secondary pulmonary function testing"><a href="/solutions/informatics/spirometry/" target="_self" data-id="pulmonary function testing" class="show-in-secondary">Pulmonary Function Testing</a></li><li class="show-in-secondary medical imaging"><a href="/solutions/informatics/medical-imaging/" target="_self" data-id="medical imaging" class="show-in-secondary">Medical Imaging</a></li><li class="show-in-secondary regulatory information management"><a href="/solutions/informatics/regulatory-information-management/" target="_self" data-id="regulatory information management" class="show-in-secondary">Regulatory Information Management</a></li><li class="show-in-secondary customer care services"><a href="/solutions/informatics/customer-care/" target="_self" data-id="customer care services" class="show-in-secondary">Customer Care Services</a></li><li class="show-in-secondary perceptive® institute training"><a href="/solutions/informatics/perceptive-institute/" target="_self" data-id="perceptive® institute training" class="show-in-secondary">Perceptive® Institute Training</a></li><li class="show-in-secondary electronic clinical outcome assessments (ecoa) omega"><a href="/solutions/informatics/clinical-outcome-assessments/" target="_self" data-id="electronic clinical outcome assessments (ecoa)" class="show-in-secondary">Electronic Clinical Outcome Assessments (eCOA)</a></li></ul></li><li class="show-in-secondary consulting"><a href="/solutions/consulting/" target="_self" data-id="consulting" class="show-in-secondary">Consulting</a><ul class="level2"><li class="show-in-secondary integrated product development alpha"><a href="/solutions/consulting/integrated-product-development/" target="_self" data-id="integrated product development" class="show-in-secondary">Integrated Product Development</a></li><li class="show-in-secondary regulatory compliance &amp; risk management"><a href="/solutions/consulting/strategic-compliance-risk-management/" target="_self" data-id="regulatory compliance &amp; risk management" class="show-in-secondary">Regulatory Compliance &amp; Risk Management</a></li><li class=" regulatory outsourcing" style="display: none;"><a href="/solutions/consulting/regulatory-outsourcing-services/" target="_self" data-id="regulatory outsourcing" class="">Regulatory Outsourcing</a></li><li class=" regulatory information management &amp; idmp solutions" style="display: none;"><a href="/solutions/consulting/idmp-solutions/" target="_self" data-id="regulatory information management &amp; idmp solutions" class="">Regulatory Information Management &amp; IDMP Solutions</a></li><li class="show-in-secondary customer care services omega"><a href="/solutions/consulting/customer-care/" target="_self" data-id="customer care services" class="show-in-secondary">Customer Care Services</a></li></ul></li><li class="show-in-secondary access omega"><a href="/solutions/access/" target="_self" data-id="access" class="show-in-secondary">Access</a><ul class="level2"><li class="show-in-secondary late-stage clinical operations alpha"><a href="/solutions/access/late-stage-clinical-operations/" target="_self" data-id="late-stage clinical operations" class="show-in-secondary">Late-Stage Clinical Operations</a></li><li class="show-in-secondary market access consulting"><a href="/solutions/access/market-access-consulting/" target="_self" data-id="market access consulting" class="show-in-secondary">Market Access Consulting</a></li><li class=" drug safety services" style="display: none;"><a href="/solutions/access/drug-safety-services/" target="_self" data-id="drug safety services" class="">Drug Safety Services</a></li><li class="show-in-secondary qsi"><a href="/solutions/access/qsi/" target="_self" data-id="qsi" class="show-in-secondary">QSI</a></li><li class="show-in-secondary medical communications"><a href="/solutions/access/medical-communications-services/" target="_self" data-id="medical communications" class="show-in-secondary">Medical Communications</a></li><li class="real-world evidence omega" style="display: none;"><a href="/solutions/access/real-world-evidence/" target="_self" data-id="real-world evidence" class="">Real-World Evidence</a></li></ul></li></ul></li><li class="show-in-secondary with_border red_bottom experience"><a href="/experience/" target="_self" data-id="experience" class="show-in-secondary with_border red_bottom">Experience</a><ul class="level1"><li class="show-in-secondary therapeutic expertise alpha"><a href="/experience/therapeutic-expertise/" target="_self" data-id="therapeutic expertise" class="show-in-secondary">Therapeutic Expertise</a><ul class="level2"><li class="oncology alpha" style="display: none;"><a href="/experience/therapeutic-expertise/oncology-hematology/" target="_self" data-id="oncology" class="">Oncology</a></li><li class=" cardiovascular &amp; metabolic diseases" style="display: none;"><a href="/experience/therapeutic-expertise/cardiovascular-metabolic-diseases/" target="_self" data-id="cardiovascular &amp; metabolic diseases" class="">Cardiovascular &amp; Metabolic Diseases</a></li><li class=" central nervous system (cns) disorders" style="display: none;"><a href="/experience/therapeutic-expertise/central-nervous-system-cns-disorders/" target="_self" data-id="central nervous system (cns) disorders" class="">Central Nervous System (CNS) Disorders</a></li><li class=" infectious disease" style="display: none;"><a href="/experience/therapeutic-expertise/infectious-diseases/" target="_self" data-id="infectious disease" class="">Infectious Disease</a></li><li class=" respiratory capabilities" style="display: none;"><a href="/experience/therapeutic-expertise/respiratory-capabilities/" target="_self" data-id="respiratory capabilities" class="">Respiratory Capabilities</a></li><li class="rheumatology &amp; immunology capabilities omega" style="display: none;"><a href="/experience/therapeutic-expertise/rheumatology-immunology-capabilities/" target="_self" data-id="rheumatology &amp; immunology capabilities" class="">Rheumatology &amp; Immunology Capabilities</a></li></ul></li><li class="show-in-secondary industry expertise"><a href="/experience/industry-expertise/" target="_self" data-id="industry expertise" class="show-in-secondary">Industry Expertise</a><ul class="level2"><li class="pharmaceuticals alpha" style="display: none;"><a href="/experience/industry-expertise/pharmaceuticals/" target="_self" data-id="pharmaceuticals" class="">Pharmaceuticals</a></li><li class=" medical devices" style="display: none;"><a href="/experience/industry-expertise/medical-devices/" target="_self" data-id="medical devices" class="">Medical Devices</a></li><li class=" biologics" style="display: none;"><a href="/experience/industry-expertise/biologics/" target="_self" data-id="biologics" class="">Biologics</a></li><li class="biosimilars omega" style="display: none;"><a href="/experience/industry-expertise/biosimilars/" target="_self" data-id="biosimilars" class="">Biosimilars</a></li></ul></li><li class="show-in-secondary regulatory expertise"><a href="/experience/regulatory-expertise/" target="_self" data-id="regulatory expertise" class="show-in-secondary">Regulatory Expertise</a></li><li class="show-in-secondary market access expertise"><a href="/experience/market-access-expertise/" target="_self" data-id="market access expertise" class="show-in-secondary">Market Access Expertise</a></li><li class="show-in-secondary global presence"><a href="/experience/global-presence/" target="_self" data-id="global presence" class="show-in-secondary">Global Presence</a><ul class="level2"><li class="north america alpha" style="display: none;"><a href="/experience/global-presence/north-america/" target="_self" data-id="north america" class="">North America</a></li><li class=" south america" style="display: none;"><a href="/experience/global-presence/south-america/" target="_self" data-id="south america" class="">South America</a></li><li class=" europe" style="display: none;"><a href="/experience/global-presence/europe/" target="_self" data-id="europe" class="">Europe</a></li><li class=" asia" style="display: none;"><a href="/experience/global-presence/asia/" target="_self" data-id="asia" class="">Asia</a></li><li class=" middle east &amp; africa" style="display: none;"><a href="/experience/global-presence/middle-east-africa/" target="_self" data-id="middle east &amp; africa" class="">Middle East &amp; Africa</a></li><li class="emerging markets omega" style="display: none;"><a href="/experience/global-presence/emerging-markets/" target="_self" data-id="emerging markets" class="">Emerging Markets</a></li></ul></li><li class="show-in-secondary delivery models omega"><a href="/experience/delivery-models/" target="_self" data-id="delivery models" class="show-in-secondary">Delivery Models</a><ul class="level2"><li class="strategic partnerships alpha" style="display: none;"><a href="/experience/delivery-models/strategic-partnerships/" target="_self" data-id="strategic partnerships" class="">Strategic Partnerships</a></li><li class=" functional services" style="display: none;"><a href="/experience/delivery-models/functional-services/" target="_self" data-id="functional services" class="">Functional Services</a></li><li class="parexel® biopharm unit omega" style="display: none;"><a href="/experience/delivery-models/biopharm/" target="_self" data-id="parexel® biopharm unit" class="">PAREXEL® BioPharm Unit</a></li></ul></li></ul></li><li class="nav-path-selected company" style="display: none;"><a href="/company/" target="_self" data-id="company" class="nav-path-selected">Company</a><ul class="level1"><li class="management team alpha" style="display: none;"><a href="/company/management-team/" target="_self" data-id="management team" class="">Management Team</a><ul class="level2"><li class="josef h. von rickenbach alpha" style="display: none;"><a href="/company/management-team/josef-von-rickenbach/" target="_self" data-id="josef h. von rickenbach" class="">Josef H. von Rickenbach</a></li><li class=" mark a. goldberg, m.d." style="display: none;"><a href="/company/management-team/mark-goldberg-md/" target="_self" data-id="mark a. goldberg, m.d." class="">Mark A. Goldberg, M.D.</a></li><li class=" roland andersson, ph.d." style="display: none;"><a href="/company/management-team/roland-andersson-phd/" target="_self" data-id="roland andersson, ph.d." class="">Roland Andersson, Ph.D.</a></li><li class=" ingo bank" style="display: none;"><a href="/company/management-team/ingo-bank/" target="_self" data-id="ingo bank" class="">Ingo Bank</a></li><li class=" douglas a. batt" style="display: none;"><a href="/company/management-team/douglas-batt/" target="_self" data-id="douglas a. batt" class="">Douglas A. Batt</a></li><li class=" xavier flinois" style="display: none;"><a href="/company/management-team/xavier-flinois/" target="_self" data-id="xavier flinois" class="">Xavier Flinois</a></li><li class=" gadi saarony" style="display: none;"><a href="/company/management-team/gadi-saarony/" target="_self" data-id="gadi saarony" class="">Gadi Saarony</a></li><li class="ulf schneider, ph.d. omega" style="display: none;"><a href="/company/management-team/ulf-schneider-phd/" target="_self" data-id="ulf schneider, ph.d." class="">Ulf Schneider, Ph.D.</a></li></ul></li><li class=" news &amp; events" style="display: none;"><a href="/company/news-events/" target="_self" data-id="news &amp; events" class="">News &amp; Events</a><ul class="level2"><li class="press releases alpha" style="display: none;"><a href="/company/news-events/press-releases/" target="_self" data-id="press releases" class="">Press Releases</a></li><li class=" events" style="display: none;"><a href="/company/news-events/events/" target="_self" data-id="events" class="">Events</a></li><li class=" webinars" style="display: none;"><a href="/company/news-events/webinars/" target="_self" data-id="webinars" class="">Webinars</a></li><li class=" 12th annual partnerships in clinical trials congress" style="display: none;"><a href="/company/news-events/12th-annual-partnerships-clinical-trials-congress/" target="_self" data-id="12th annual partnerships in clinical trials congress" class="">12th Annual Partnerships in Clinical Trials Congress</a></li><li class="archived parexel in the news omega" style="display: none;"><a href="/company/news-events/archived-parexel-news/" target="_self" data-id="archived parexel in the news" class="">Archived PAREXEL in the News</a></li></ul></li><li class=" find an office" style="display: none;"><a href="/company/locations-and-offices/" target="_self" data-id="find an office" class="">Find an Office</a><ul class="level2"><li class="basel, switzerland alpha omega" style="display: none;"><a href="/company/locations-and-offices/basel-switzerlan/" target="_self" data-id="basel, switzerland" class="">Basel, Switzerland</a></li></ul></li><li class=" investors" style="display: none;"><a href="http://investor.parexel.com/" target="_blank" data-id="investors" class="">Investors</a></li><li class=" careers" style="display: none;"><a href="/company/careers/" target="_self" data-id="careers" class="">Careers</a><ul class="level2"><li class="careers at parexel® alpha" style="display: none;"><a href="/company/careers/careers-parexel/" target="_self" data-id="careers at parexel®" class="">Careers at PAREXEL®</a></li><li class=" ceo message" style="display: none;"><a href="/company/careers/ceo-message/" target="_self" data-id="ceo message" class="">CEO Message</a></li><li class=" find your path - opportunities" style="display: none;"><a href="https://jobs.parexel.com" target="_blank" data-id="find your path - opportunities" class="">Find Your Path - Opportunities</a></li><li class="university graduates – opportunities for students omega" style="display: none;"><a href="/company/careers/university-graduates-opportunities-students/" target="_self" data-id="university graduates – opportunities for students" class="">University Graduates – Opportunities for students</a></li></ul></li><li class=" volunteer" style="display: none;"><a href="/company/volunteer/" target="_self" data-id="volunteer" class="">Volunteer</a><ul class="level2"><li class="about us alpha" style="display: none;"><a href="/company/volunteer/about-us/" target="_self" data-id="about us" class="">About Us</a></li><li class=" locations worldwide" style="display: none;"><a href="/company/volunteer/locations-worldwide/" target="_self" data-id="locations worldwide" class="">Locations Worldwide</a></li><li class=" about clinical trials" style="display: none;"><a href="/company/volunteer/about-clinical-trials/" target="_self" data-id="about clinical trials" class="">About Clinical Trials</a></li><li class=" why participate?" style="display: none;"><a href="/company/volunteer/why-participate/" target="_self" data-id="why participate?" class="">Why Participate?</a></li><li class=" faqs" style="display: none;"><a href="/company/volunteer/faqs/" target="_self" data-id="faqs" class="">FAQs</a></li><li class="glossary omega" style="display: none;"><a href="/company/volunteer/glossary/" target="_self" data-id="glossary" class="">Glossary</a></li></ul></li><li class=" sustainability" style="display: none;"><a href="/company/sustainability/" target="_self" data-id="sustainability" class="">Sustainability</a><ul class="level2"><li class="consumption trend analysis alpha omega" style="display: none;"><a href="/company/sustainability/consumption-trend-analysis/" target="_self" data-id="consumption trend analysis" class="">Consumption Trend Analysis</a></li></ul></li><li class=" code of conduct" style="display: none;"><a href="/company/code-conduct/" target="_self" data-id="code of conduct" class="">Code of Conduct</a></li><li class=" eclinical innovation" style="display: none;"><a href="/company/eclinical-innovation/" target="_self" data-id="eclinical innovation" class="">eClinical Innovation</a></li><li class=" purchasing" style="display: none;"><a href="/company/purchasing/" target="_self" data-id="purchasing" class="">Purchasing</a><ul class="level2"><li class="purchase order terms and conditions alpha" style="display: none;"><a href="/company/purchasing/purchase-order-terms-and-conditions/" target="_self" data-id="purchase order terms and conditions" class="">Purchase Order Terms and Conditions</a></li><li class=" bedingungen für den kaufauftrag" style="display: none;"><a href="/company/purchasing/bedingungen-fur-den-kaufauftrag/" target="_self" data-id="bedingungen für den kaufauftrag" class="">Bedingungen für den Kaufauftrag</a></li><li class=" vigente desde el" style="display: none;"><a href="/company/purchasing/vigente-desde-el/" target="_self" data-id="vigente desde el" class="">Vigente desde el</a></li><li class=" po terms - japanese" style="display: none;"><a href="/company/purchasing/po-terms/" target="_self" data-id="po terms - japanese" class="">PO Terms - Japanese</a></li><li class=" po terms - chinese 's'" style="display: none;"><a href="/company/purchasing/po-terms-chinese-s/" target="_self" data-id="po terms - chinese 's'" class="">PO Terms - Chinese 'S'</a></li><li class=" po terms - chinese 't'" style="display: none;"><a href="/company/purchasing/po-terms-chinese-t/" target="_self" data-id="po terms - chinese 't'" class="">PO Terms - Chinese 'T'</a></li><li class="ordem de compra termos e condições omega" style="display: none;"><a href="/company/purchasing/ordem-de-compra-termos-e-condicoes/" target="_self" data-id="ordem de compra termos e condições" class="">Ordem de Compra Termos e Condições</a></li></ul></li><li class="contact us omega" style="display: none;"><a href="/company/contact/" target="_self" data-id="contact us" class="">Contact Us</a><ul class="level2"><li class="thank you alpha omega" style="display: none;"><a href="/company/contact/thank-you/" target="_self" data-id="thank you" class="">Thank You</a></li></ul></li></ul></li><li class=" perceptive®" style="display: none;"><a href="/perceptive/" target="_self" data-id="perceptive®" class="">Perceptive®</a></li><li class=" user group meeting" style="display: none;"><a href="/user-group-meeting/" target="_self" data-id="user group meeting" class="">User Group Meeting</a><ul class="level1"><li class="impact ctms user group meeting details and agendas alpha" style="display: none;"><a href="/user-group-meeting/user-group-meeting-details-and-agendas/" target="_self" data-id="impact ctms user group meeting details and agendas" class="">IMPACT CTMS User Group Meeting Details and Agendas</a></li><li class=" impact ctms user group meeting justification letter" style="display: none;"><a href="/user-group-meeting/user-group-meeting-justification-letter/" target="_self" data-id="impact ctms user group meeting justification letter" class="">IMPACT CTMS User Group Meeting Justification Letter</a></li><li class=" meeting registration and hotel details" style="display: none;"><a href="/user-group-meeting/meeting-registration-and-hotel-details/" target="_self" data-id="meeting registration and hotel details" class="">Meeting Registration and Hotel Details</a></li><li class=" benefits for attending the impact ctms user group meeting" style="display: none;"><a href="/user-group-meeting/benefits-attending-user-group-meeting/" target="_self" data-id="benefits for attending the impact ctms user group meeting" class="">Benefits for attending the IMPACT CTMS User Group Meeting</a></li><li class=" registration rates" style="display: none;"><a href="/user-group-meeting/registration-rates/" target="_self" data-id="registration rates" class="">Registration Rates</a></li><li class="hotel rates omega" style="display: none;"><a href="/user-group-meeting/hotel-rates/" target="_self" data-id="hotel rates" class="">Hotel Rates</a></li></ul></li><li class=" graduate" style="display: none;"><a href="/graduate/" target="_self" data-id="graduate" class="">Graduate</a></li><li class=" parexel-insights" style="display: none;"><a href="/parexel-insights/" target="_self" data-id="parexel-insights" class="">parexel-insights</a><ul class="level1"><li class="training compliance is an increasingly complex journey alpha" style="display: none;"><a href="/parexel-insights/training-compliance-increasingly-complex-journey/" target="_self" data-id="training compliance is an increasingly complex journey" class="">Training Compliance is an Increasingly Complex Journey</a></li><li class=" beyond diversity: what happens when you define a culture of inclusion" style="display: none;"><a href="/parexel-insights/beyond-diversity-what-happens-when-you-define-culture-inclusion/" target="_self" data-id="beyond diversity: what happens when you define a culture of inclusion" class="">Beyond Diversity: What Happens When You Define a Culture of Inclusion</a></li><li class=" the next generation of talent management: opportunities for diversity" style="display: none;"><a href="/parexel-insights/next-generation-talent-management-opportunities-diversity/" target="_self" data-id="the next generation of talent management: opportunities for diversity" class="">The Next Generation of Talent Management: Opportunities For Diversity</a></li><li class=" get into pole position with modern irt services" style="display: none;"><a href="/parexel-insights/get-pole-position-modern-irt-services-clinical-trials/" target="_self" data-id="get into pole position with modern irt services" class="">Get Into Pole Position with Modern IRT Services</a></li><li class=" when it comes to ctms one size does not fit all" style="display: none;"><a href="/parexel-insights/when-it-comes-ctms-one-size-does-not-fit-all/" target="_self" data-id="when it comes to ctms one size does not fit all" class="">When It Comes to CTMS One Size Does Not Fit All</a></li><li class=" protocol optimization" style="display: none;"><a href="/parexel-insights/protocol-optimization/" target="_self" data-id="protocol optimization" class="">Protocol Optimization</a></li><li class=" using analytics to optimize the clinical development process" style="display: none;"><a href="/parexel-insights/using-analytics-optimize-clinical-development-process/" target="_self" data-id="using analytics to optimize the clinical development process" class="">Using Analytics to Optimize The Clinical Development Process</a></li><li class=" shogo nakamori discusses joint program for clinical research" style="display: none;"><a href="/parexel-insights/parexel-shogo-nakamori-speaks-about-new-joint-program-clinical-research-japan/" target="_self" data-id="shogo nakamori discusses joint program for clinical research" class="">Shogo Nakamori Discusses Joint Program for Clinical Research</a></li><li class=" josh schultz, corp. vp talks about parexel access" style="display: none;"><a href="/parexel-insights/josh-schultz-corp-vp-talks-about-parexel-access/" target="_self" data-id="josh schultz, corp. vp talks about parexel access" class="">Josh Schultz, Corp. VP Talks About PAREXEL Access</a></li><li class=" new approaches to data management in clinical trials" style="display: none;"><a href="/parexel-insights/new-approaches-data-management-todays-clinical-trials/" target="_self" data-id="new approaches to data management in clinical trials" class="">New Approaches to Data Management in Clinical Trials</a></li><li class=" shogo nakamori discusses japan &amp; multi-national trials" style="display: none;"><a href="/parexel-insights/shogo-nakamori-discusses-japans-involvement-multi-national-trials/" target="_self" data-id="shogo nakamori discusses japan &amp; multi-national trials" class="">Shogo Nakamori Discusses Japan &amp; Multi-national Trials</a></li><li class=" shogo nakamori discusses trends in drug development in japan" style="display: none;"><a href="/parexel-insights/shogo-nakamori-discusses-trends-drug-development-japan/" target="_self" data-id="shogo nakamori discusses trends in drug development in japan" class="">Shogo Nakamori Discusses Trends in Drug Development in Japan</a></li><li class=" involved &amp; engaged: the last mile of business performance" style="display: none;"><a href="/parexel-insights/everyone-involved-everyone-engaged-last-mile-business-performance/" target="_self" data-id="involved &amp; engaged: the last mile of business performance" class="">Involved &amp; Engaged: The Last Mile of Business Performance</a></li><li class=" why rtsm &amp; irt stand for speed, simplicity &amp; service" style="display: none;"><a href="/parexel-insights/why-rtsm-and-irt-really-stand-speed-simplicity-and-service/" target="_self" data-id="why rtsm &amp; irt stand for speed, simplicity &amp; service" class="">Why RTSM &amp; IRT stand for Speed, Simplicity &amp; Service</a></li><li class=" dream or reality- improving patient safety &amp; reducing costs?" style="display: none;"><a href="/parexel-insights/holy-grail-improving-patient-safety-while-reducing-costs/" target="_self" data-id="dream or reality- improving patient safety &amp; reducing costs?" class="">Dream or Reality- Improving Patient Safety &amp; Reducing Costs?</a></li><li class=" drew garty discusses data driven monitoring" style="display: none;"><a href="/parexel-insights/drew-garty-discusses-data-driven-monitoring/" target="_self" data-id="drew garty discusses data driven monitoring" class="">Drew Garty Discusses Data Driven Monitoring</a></li><li class=" albert liou discusses the drug development landscape in korea" style="display: none;"><a href="/parexel-insights/albert-liou-discusses-drug-development-landscape-korea/" target="_self" data-id="albert liou discusses the drug development landscape in korea" class="">Albert Liou Discusses the Drug Development Landscape in Korea</a></li><li class=" roland andersson, svp, discusses investing trends and emerging biopharmaceutical companies" style="display: none;"><a href="/parexel-insights/roland-andersson-svp-discusses-investing-trends-and-emerging-biopharmaceutical-companies/" target="_self" data-id="roland andersson, svp, discusses investing trends and emerging biopharmaceutical companies" class="">Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies</a></li><li class=" mark a. goldberg, president &amp; coo, discusses parexel’s acquisition of quantum solutions india (qsi)" style="display: none;"><a href="/parexel-insights/mark-goldberg-president-coo-discusses-parexels-acquisition-quantum-solutions-india-qsi/" target="_self" data-id="mark a. goldberg, president &amp; coo, discusses parexel’s acquisition of quantum solutions india (qsi)" class="">Mark A. Goldberg, President &amp; COO, Discusses PAREXEL’s Acquisition of Quantum Solutions India (QSI)</a></li><li class=" albert siu, phd, explains how parexel academy benefits clients" style="display: none;"><a href="/parexel-insights/albert-sui-phd-explains-how-parexel-academy-benefits-clients/" target="_self" data-id="albert siu, phd, explains how parexel academy benefits clients" class="">Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients</a></li><li class=" ubavka denoble talks about parexel's biopharm unit" style="display: none;"><a href="/parexel-insights/ubavka-denoble-talks-about-parexels-biopharm-unit/" target="_self" data-id="ubavka denoble talks about parexel's biopharm unit" class="">Ubavka DeNoble Talks About PAREXEL's BioPharm Unit</a></li><li class=" dr. sy pretorius, chief scientific officer talks about adaptive design trials" style="display: none;"><a href="/parexel-insights/dr-sy-pretorius-chief-scientific-officer-talks-about-adaptive-design-trials/" target="_self" data-id="dr. sy pretorius, chief scientific officer talks about adaptive design trials" class="">Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials</a></li><li class=" parexel’s training approach and the importance of training a global workforce" style="display: none;"><a href="/parexel-insights/parexels-training-approach-and-importance-training-global-workforce/" target="_self" data-id="parexel’s training approach and the importance of training a global workforce" class="">PAREXEL’s Training Approach and the Importance of Training a Global Workforce</a></li><li class=" clinical trial support query - who ya gonna call?" style="display: none;"><a href="/parexel-insights/clinical-trial-support-query-who-ya-gonna-call/" target="_self" data-id="clinical trial support query - who ya gonna call?" class="">Clinical Trial Support Query - Who Ya Gonna Call?</a></li><li class=" 3 examples of breakthrough analytics at dia china - social media, recruitment &amp; monitoring" style="display: none;"><a href="/parexel-insights/3-examples-breakthrough-analytics-dia-china-social-media-recruitment-monitoring/" target="_self" data-id="3 examples of breakthrough analytics at dia china - social media, recruitment &amp; monitoring" class="">3 Examples of Breakthrough Analytics at DIA China - Social Media, Recruitment &amp; Monitoring</a></li><li class=" clinical trial feasibility &amp; patient enrollment: differentiation through innovation" style="display: none;"><a href="/parexel-insights/clinical-trial-feasibility-and-patient-enrollment-differentiation-through-innovation/" target="_self" data-id="clinical trial feasibility &amp; patient enrollment: differentiation through innovation" class="">Clinical Trial Feasibility &amp; Patient Enrollment: Differentiation Through Innovation</a></li><li class=" innovation in the pharmaceutical industry: a change toward personalized medicine" style="display: none;"><a href="/parexel-insights/innovation-pharmaceutical-industry-change-toward-personalized-medicine/" target="_self" data-id="innovation in the pharmaceutical industry: a change toward personalized medicine" class="">Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine</a></li><li class=" a biosimilar milestone with implications" style="display: none;"><a href="/parexel-insights/biosimilar-milestone-implications/" target="_self" data-id="a biosimilar milestone with implications" class="">A Biosimilar Milestone with Implications</a></li><li class=" designing trials payers can trust" style="display: none;"><a href="/parexel-insights/designing-trials-payers-can-trust/" target="_self" data-id="designing trials payers can trust" class="">Designing Trials Payers Can Trust</a></li><li class=" the human touch: aligning reward systems with company strategy and meaningful work" style="display: none;"><a href="/parexel-insights/human-touch-aligning-reward-systems-company-strategy-and-meaningful-work/" target="_self" data-id="the human touch: aligning reward systems with company strategy and meaningful work" class="">The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work</a></li><li class=" diversity and inclusion: this is how the best global companies learn, plan, and measure success" style="display: none;"><a href="/parexel-insights/diversity-and-inclusion-how-best-global-companies-learn-plan-and-measure-success/" target="_self" data-id="diversity and inclusion: this is how the best global companies learn, plan, and measure success" class="">Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success</a></li><li class=" accelerated pathways and stock prices" style="display: none;"><a href="/parexel-insights/accelerated-pathways-and-stock-prices/" target="_self" data-id="accelerated pathways and stock prices" class="">Accelerated Pathways and Stock Prices</a></li><li class=" accelerated pathways &amp; commercial consequences forum &amp; findings" style="display: none;"><a href="/parexel-insights/accelerated-pathways-commercial-consequences-forum-findings/" target="_self" data-id="accelerated pathways &amp; commercial consequences forum &amp; findings" class="">Accelerated Pathways &amp; Commercial Consequences Forum &amp; Findings</a></li><li class=" accelerated pathways: global opportunities &amp; challenges for innovators" style="display: none;"><a href="/parexel-insights/accelerated-pathways-global-opportunities-challenges-innovators/" target="_self" data-id="accelerated pathways: global opportunities &amp; challenges for innovators" class="">Accelerated Pathways: Global Opportunities &amp; Challenges for Innovators</a></li><li class="interview with parexel’s aida sabo, about challenges and successes in diversity and inclusion omega" style="display: none;"><a href="/parexel-insights/interview-parexels-aida-sabo-about-challenges-and-successes-diversity-and-inclusion/" target="_self" data-id="interview with parexel’s aida sabo, about challenges and successes in diversity and inclusion" class="">Interview with PAREXEL’s Aida Sabo, About Challenges and Successes in Diversity and Inclusion</a></li></ul></li><li class=" agile-irt" style="display: none;"><a href="/agile-irt/" target="_self" data-id="agile-irt" class="">agile-IRT</a><ul class="level1"><li class="agile irt alpha" style="display: none;"><a href="/agile-irt/agile/" target="_self" data-id="agile irt" class="">Agile IRT</a></li><li class=" reduced timelines" style="display: none;"><a href="/agile-irt/reduced-timelines/" target="_self" data-id="reduced timelines" class="">Reduced Timelines</a></li><li class=" simpler processes" style="display: none;"><a href="/agile-irt/simple/" target="_self" data-id="simpler processes" class="">Simpler Processes</a></li><li class=" expert services" style="display: none;"><a href="/agile-irt/expert-services/" target="_self" data-id="expert services" class="">Expert Services</a></li><li class="contact omega" style="display: none;"><a href="/agile-irt/contact/" target="_self" data-id="contact" class="">Contact</a></li></ul></li><li class=" test" style="display: none;"><a href="/test/" target="_self" data-id="test" class="">test</a></li><li class="access hub omega" style="display: none;"><a href="/access-hub/" target="_self" data-id="access hub" class="">Access Hub</a><ul class="level1"><li class="real-world evidence of treatment pattern and costs of fibromyalgia alpha" style="display: none;"><a href="/access-hub/real-world-evidence-fibromyalgia/" target="_self" data-id="real-world evidence of treatment pattern and costs of fibromyalgia" class="">Real-world evidence of treatment pattern and costs of Fibromyalgia</a></li><li class=" three steps for filling real-world evidence gaps" style="display: none;"><a href="/access-hub/three-steps-filling-real-world-evidence-gaps/" target="_self" data-id="three steps for filling real-world evidence gaps" class="">Three steps for filling real-world evidence gaps</a></li><li class=" how to engage external partners to gain market access" style="display: none;"><a href="/access-hub/how-engage-external-partners-gain-market-access/" target="_self" data-id="how to engage external partners to gain market access" class="">How to engage external partners to gain market access</a></li><li class=" not ready for the real world?" style="display: none;"><a href="/access-hub/not-ready-real-world/" target="_self" data-id="not ready for the real world?" class="">Not ready for the real world?</a></li><li class=" a hybrid approach to post-approval research" style="display: none;"><a href="/access-hub/hybrid-approach-post-approval-research/" target="_self" data-id="a hybrid approach to post-approval research" class="">A hybrid approach to post-approval research</a></li><li class=" optimize data collection in prospective study designs" style="display: none;"><a href="/access-hub/1-optimize-data-collection-prospective-study-designs/" target="_self" data-id="optimize data collection in prospective study designs" class="">Optimize data collection in prospective study designs</a></li><li class=" fda’s accelerated pathways are the new normal" style="display: none;"><a href="/access-hub/fdas-accelerated-pathways-are-new-normal/" target="_self" data-id="fda’s accelerated pathways are the new normal" class="">FDA’s accelerated pathways are the new normal</a></li><li class=" playing defense in a riskier commercial environment for cancer drugs" style="display: none;"><a href="/access-hub/playing-defense-riskier-commercial-environment-cancer-drugs/" target="_self" data-id="playing defense in a riskier commercial environment for cancer drugs" class="">Playing defense in a riskier commercial environment for cancer drugs</a></li><li class=" the rise of indication-specific pricing in the uk?" style="display: none;"><a href="/access-hub/rise-indication-specific-pricing-uk/" target="_self" data-id="the rise of indication-specific pricing in the uk?" class="">The rise of indication-specific pricing in the UK?</a></li><li class=" three drug development habits to mitigate commercial risk" style="display: none;"><a href="/access-hub/three-drug-development-habits-mitigate-commercial-risk/" target="_self" data-id="three drug development habits to mitigate commercial risk" class="">Three drug development habits to mitigate commercial risk</a></li><li class=" strengthen your product value story one phase at a time" style="display: none;"><a href="/access-hub/strengthen-your-product-value-story-one-phase-time/" target="_self" data-id="strengthen your product value story one phase at a time" class="">Strengthen your product value story one phase at a time</a></li><li class=" commercial consequences of expedited approval" style="display: none;"><a href="/access-hub/completed-payer-survey-covering-all/" target="_self" data-id="commercial consequences of expedited approval" class="">Commercial consequences of expedited approval</a></li><li class=" 5 benefits of building a robust evidence platform" style="display: none;"><a href="/access-hub/5-benefits-building-robust-evidence-platform/" target="_self" data-id="5 benefits of building a robust evidence platform" class="">5 benefits of building a robust evidence platform</a></li><li class=" innovation in real-world research" style="display: none;"><a href="/access-hub/innovation-real-world-research/" target="_self" data-id="innovation in real-world research" class="">Innovation in real-world research</a></li><li class=" accelerated pathways: global opportunities and challenges for innovators" style="display: none;"><a href="/access-hub/accelerated-pathways-global-opportunities-and-challenges-innovators/" target="_self" data-id="accelerated pathways: global opportunities and challenges for innovators" class="">Accelerated pathways: global opportunities and challenges for innovators</a></li><li class=" no nice – now what?" style="display: none;"><a href="/access-hub/no-nice-now-what/" target="_self" data-id="no nice – now what?" class="">No NICE – now what?</a></li><li class=" 3 steps to a successful expanded access program" style="display: none;"><a href="/access-hub/3-steps-successful-expanded-access-program/" target="_self" data-id="3 steps to a successful expanded access program" class="">3 steps to a successful expanded access program</a></li><li class=" an integrated pharmacovigilance model to meet regulatory trends" style="display: none;"><a href="/access-hub/pharmacovigilance-model-meet-new-regulatory-trends/" target="_self" data-id="an integrated pharmacovigilance model to meet regulatory trends" class="">An integrated pharmacovigilance model to meet regulatory trends</a></li><li class=" differences in hta acceptance rates across disease areas" style="display: none;"><a href="/access-hub/differences-hta-acceptance-rates-across-disease-areas/" target="_self" data-id="differences in hta acceptance rates across disease areas" class="">Differences in HTA acceptance rates across disease areas</a></li><li class=" unlocking the value of observational research" style="display: none;"><a href="/access-hub/unlocking-value-observational-research/" target="_self" data-id="unlocking the value of observational research" class="">Unlocking the value of observational research</a></li><li class=" be a step ahead at every step" style="display: none;"><a href="/access-hub/be-step-ahead-every-step/" target="_self" data-id="be a step ahead at every step" class="">Be a step ahead at every step</a><ul class="level2"><li class="walking feet alpha omega" style="display: none;"><a href="/access-hub/be-step-ahead-every-step/walking-feet/" target="_self" data-id="walking feet" class="">Walking Feet</a></li></ul></li><li class=" nothing costs more than failure" style="display: none;"><a href="/access-hub/nothing-costs-more-failure/" target="_self" data-id="nothing costs more than failure" class="">Nothing costs more than failure</a></li><li class=" real world data strategies" style="display: none;"><a href="/access-hub/real-world-data-strategies/" target="_self" data-id="real world data strategies" class="">Real world data strategies</a></li><li class=" an alternative route to market access in scotland?" style="display: none;"><a href="/access-hub/alternative-route-market-access-scotland/" target="_self" data-id="an alternative route to market access in scotland?" class="">An alternative route to market access in Scotland?</a></li><li class=" how to meet the needs of stakeholders" style="display: none;"><a href="/access-hub/how-meet-needs-stakeholders/" target="_self" data-id="how to meet the needs of stakeholders" class="">How to meet the needs of stakeholders</a></li><li class=" client oversight – benefits of a 1:15 ratio" style="display: none;"><a href="/access-hub/client-oversight-benefits-115-ratio/" target="_self" data-id="client oversight – benefits of a 1:15 ratio" class="">Client oversight – benefits of a 1:15 ratio</a></li><li class=" late phase partnerships" style="display: none;"><a href="/access-hub/late-phase-partnerships/" target="_self" data-id="late phase partnerships" class="">Late phase partnerships</a></li><li class=" does practice make perfect?" style="display: none;"><a href="/access-hub/does-practice-make-perfect/" target="_self" data-id="does practice make perfect?" class="">Does practice make perfect?</a></li><li class=" organizing internally for external value communications" style="display: none;"><a href="/access-hub/organizing-internally-external-value-communications/" target="_self" data-id="organizing internally for external value communications" class="">Organizing internally for external value communications</a></li><li class=" how to increase the impact of observational research" style="display: none;"><a href="/access-hub/how-increase-impact-observational-research/" target="_self" data-id="how to increase the impact of observational research" class="">How to increase the impact of observational research</a><ul class="level2"><li class="increasing the impact alpha omega" style="display: none;"><a href="/access-hub/how-increase-impact-observational-research/increasing-the-impact/" target="_self" data-id="increasing the impact" class="">Increasing The Impact</a></li></ul></li><li class=" webinar: how to develop a global observational study" style="display: none;"><a href="/access-hub/webinar-how-develop-global-observational-study/" target="_self" data-id="webinar: how to develop a global observational study" class="">Webinar: How to develop a global observational study</a></li><li class=" pharmacovigilance – knowledge process outsourcing (kpo)" style="display: none;"><a href="/access-hub/pharmacovigilance-knowledge-process-outsourcing-kpo/" target="_self" data-id="pharmacovigilance – knowledge process outsourcing (kpo)" class="">Pharmacovigilance – Knowledge Process Outsourcing (KPO)</a></li><li class=" how to prove comparative value" style="display: none;"><a href="/access-hub/how-prove-comparative-value/" target="_self" data-id="how to prove comparative value" class="">How to prove comparative value</a><ul class="level2"><li class="cracking the code alpha omega" style="display: none;"><a href="/access-hub/how-prove-comparative-value/cracking-the-code/" target="_self" data-id="cracking the code" class="">Cracking The Code</a></li></ul></li><li class=" case study: database solutions" style="display: none;"><a href="/access-hub/case-study-database-solutions/" target="_self" data-id="case study: database solutions" class="">Case Study: Database solutions</a></li><li class=" achieving global value from local observational research" style="display: none;"><a href="/access-hub/achieving-global-value-local-observational-research/" target="_self" data-id="achieving global value from local observational research" class="">Achieving global value from local observational research</a></li><li class=" case study: metabolic disease observational study" style="display: none;"><a href="/access-hub/case-study-metabolic-disease-observational-study/" target="_self" data-id="case study: metabolic disease observational study" class="">Case Study: Metabolic disease observational study</a></li><li class=" case study: expanded access program" style="display: none;"><a href="/access-hub/case-study-expanded-access-program/" target="_self" data-id="case study: expanded access program" class="">Case Study: Expanded access program</a></li><li class=" non-adherence in chronic myeloid leukemia" style="display: none;"><a href="/access-hub/non-adherence-chronic-myeloid-leukemia/" target="_self" data-id="non-adherence in chronic myeloid leukemia" class="">Non-adherence in Chronic Myeloid Leukemia</a></li><li class=" case study: commercialization strategy" style="display: none;"><a href="/access-hub/case-study-commercialization-strategy/" target="_self" data-id="case study: commercialization strategy" class="">Case Study: Commercialization strategy</a></li><li class=" late phase success" style="display: none;"><a href="/access-hub/late-phase-success/" target="_self" data-id="late phase success" class="">Late phase success</a><ul class="level2"><li class="late phase success video alpha omega" style="display: none;"><a href="/access-hub/late-phase-success/test-video/" target="_self" data-id="late phase success video" class="">Late Phase Success Video</a></li></ul></li><li class=" case study: rapid recruitment" style="display: none;"><a href="/access-hub/case-study-rapid-recruitment/" target="_self" data-id="case study: rapid recruitment" class="">Case Study: Rapid recruitment</a></li><li class=" spanish therapeutic positioning reports" style="display: none;"><a href="/access-hub/spanish-therapeutic-positioning-reports/" target="_self" data-id="spanish therapeutic positioning reports" class="">Spanish therapeutic positioning reports</a></li><li class=" expanded access program: navigating the when, who and how" style="display: none;"><a href="/access-hub/navigating-when-who-and-how/" target="_self" data-id="expanded access program: navigating the when, who and how" class="">Expanded Access Program: Navigating the When, Who and How</a></li><li class=" price globally. negotiate locally." style="display: none;"><a href="/access-hub/price-globally-negotiate-locally/" target="_self" data-id="price globally. negotiate locally." class="">Price globally. Negotiate locally.</a></li><li class=" case study: site identification &amp; qualification" style="display: none;"><a href="/access-hub/case-study-site-identification-qualification/" target="_self" data-id="case study: site identification &amp; qualification" class="">Case Study: Site identification &amp; qualification</a></li><li class=" case study: complex data collection" style="display: none;"><a href="/access-hub/case-study-complex-data-collection/" target="_self" data-id="case study: complex data collection" class="">Case Study: Complex data collection</a></li><li class=" how to prepare for product commercialization" style="display: none;"><a href="/access-hub/how-prepare-product-commercialization/" target="_self" data-id="how to prepare for product commercialization" class="">How to prepare for product commercialization</a></li><li class=" how to build a study global value dossier" style="display: none;"><a href="/access-hub/how-build-study-global-value-dossier/" target="_self" data-id="how to build a study global value dossier" class="">How to build a study global value dossier</a></li><li class=" how to use market access data for successful product launch" style="display: none;"><a href="/access-hub/how-use-market-access-data-successful-product-launch/" target="_self" data-id="how to use market access data for successful product launch" class="">How to use market access data for successful product launch</a></li><li class=" understanding data-driven monitoring" style="display: none;"><a href="/access-hub/understanding-data-driven-monitoring/" target="_self" data-id="understanding data-driven monitoring" class="">Understanding data-driven monitoring</a></li><li class=" delivering data that supports your value argument" style="display: none;"><a href="/access-hub/delivering-data-supports-your-value-argument/" target="_self" data-id="delivering data that supports your value argument" class="">Delivering data that supports your value argument</a></li><li class=" product approval demands real-world evidence" style="display: none;"><a href="/access-hub/product-approval-demands-real-world-evidence/" target="_self" data-id="product approval demands real-world evidence" class="">Product approval demands real-world evidence</a></li><li class=" what is the value of a qaly?" style="display: none;"><a href="/access-hub/what-value-qaly/" target="_self" data-id="what is the value of a qaly?" class="">What is the value of a QALY?</a></li><li class=" how to design a trial payers can trust" style="display: none;"><a href="/access-hub/how-design-trial-payers-can-trust/" target="_self" data-id="how to design a trial payers can trust" class="">How to design a trial payers can trust</a></li><li class=" cost effectiveness modelling" style="display: none;"><a href="/access-hub/cost-effectiveness-modelling/" target="_self" data-id="cost effectiveness modelling" class="">Cost effectiveness modelling</a></li><li class=" non-adherence in patients with breast cancer: a systematic review" style="display: none;"><a href="/access-hub/12-non-adherence-patients-breast-cancer-systematic-review/" target="_self" data-id="non-adherence in patients with breast cancer: a systematic review" class="">Non-adherence in patients with Breast Cancer: A systematic review</a></li><li class=" early economic models pay off" style="display: none;"><a href="/access-hub/early-economic-models-pay/" target="_self" data-id="early economic models pay off" class="">Early economic models pay off</a></li><li class=" the path to better clinical trial design" style="display: none;"><a href="/access-hub/path-better-clinical-trial-design/" target="_self" data-id="the path to better clinical trial design" class="">The path to better clinical trial design</a></li><li class=" five steps to winning market share" style="display: none;"><a href="/access-hub/five-steps-winning-market-share/" target="_self" data-id="five steps to winning market share" class="">Five steps to winning market share</a></li><li class=" the importance of building value with real-world data" style="display: none;"><a href="/access-hub/importance-building-value-real-world-data/" target="_self" data-id="the importance of building value with real-world data" class="">The importance of building value with real-world data</a></li><li class=" are the smc getting nicer?" style="display: none;"><a href="/access-hub/are-smc-getting-nicer/" target="_self" data-id="are the smc getting nicer?" class="">Are the SMC getting NICEr?</a></li><li class=" price optimization – a global strategy for local markets" style="display: none;"><a href="/access-hub/price-optimization-global-strategy-local-markets/" target="_self" data-id="price optimization – a global strategy for local markets" class="">Price Optimization – A Global Strategy for Local Markets</a></li><li class=" bringing drugs to market early" style="display: none;"><a href="/access-hub/bringing-drugs-market-early/" target="_self" data-id="bringing drugs to market early" class="">Bringing drugs to market early</a></li><li class=" discover how our teams work together for a bigger picture" style="display: none;"><a href="/access-hub/discover-how-our-teams-work-together-bigger-picture/" target="_self" data-id="discover how our teams work together for a bigger picture" class="">Discover how our teams work together for a bigger picture</a><ul class="level2"><li class="paint by fish alpha omega" style="display: none;"><a href="/access-hub/discover-how-our-teams-work-together-bigger-picture/paint-by-fish/" target="_self" data-id="paint by fish" class="">Paint By Fish</a></li></ul></li><li class=" how to build a robust argument of value" style="display: none;"><a href="/access-hub/how-build-robust-argument-value/" target="_self" data-id="how to build a robust argument of value" class="">How to build a robust argument of value</a></li><li class=" comparative effectiveness research: are we there yet?" style="display: none;"><a href="/access-hub/comparative-effectiveness-research-are-we-there-yet/" target="_self" data-id="comparative effectiveness research: are we there yet?" class="">Comparative effectiveness research: Are we there yet?</a></li><li class=" how to use evidence-based prioritization" style="display: none;"><a href="/access-hub/how-use-evidence-based-prioritization/" target="_self" data-id="how to use evidence-based prioritization" class="">How to use evidence-based prioritization</a></li><li class="new science demands real-world data omega" style="display: none;"><a href="/access-hub/new-science-demands-real-world-data/" target="_self" data-id="new science demands real-world data" class="">New science demands real-world data</a></li></ul></li></ul>
<script type="text/javascript" charset="utf-8">
	$(document).ready(function(){
		$('ul').each(function(i){
			$('> li', this).first().addClass('alpha');
			$('> li', this).last().addClass('omega');
		});
		$(".level2").hover(function(){
			$(this).parent('li').addClass('active');
		}, function() {
			$(this).parent('li').removeClass('active');
		});
	});
</script>								<ul><li id="mobile-menu-item" class="show-in-secondary with_border red_bottom journey alpha omega"><a href="#open-mobile-menu" target="_self" data-id="open-mobile-menu" class="show-in-secondary with_border red_bottom">Menu</a></li></ul>
							</nav>
							<div id="main_nav_right">
								<div class="searcher">
									<form action="/search-results/" method="get" class="ccm-search-block-form" id="nav_search">
										<input name="search_paths[]" type="hidden" value="">
										<input name="query" type="text" class="ccm-search-block-text" placeholder="SEARCH">
										<input name="submit" type="submit" value="Search" class="ccm-search-block-submit">
									</form>								
								</div>
							</div>
						</div>
					<div class="clear"></div>
				</div>
			</div>
			<div class="container">
				<div class="header-logo">
					<a href="/"></a>
				</div>	
				
				<ul class="social_media">
					<li class="twitter alpha"><a href="https://twitter.com/PAREXEL" target="_blank"><span></span></a></li>
					<li class="linkedin"><a href="https://www.linkedin.com/company/parexel" target="_blank"><span></span></a></li>
					<li class="facebook"><a href="https://www.facebook.com/Parexel" target="_blank"><span></span></a></li>
					<li class="youtube omega"><a href="https://www.youtube.com/user/PAREXELInternational" target="_blank"><span></span></a></li>
				</ul>

				<div class="clear"></div>
			</div>
			<div id="breadcrumb-container">
				<div class="container">
					<nav id="breadcrumb">
							<a class="breadcrumb-inactive" href="/" target="_self">Home</a> <span class="ccm-autonav-breadcrumb-sep">&gt;</span> <a class="breadcrumb-inactive" href="/company/" target="_self">Company</a> <span class="ccm-autonav-breadcrumb-sep">&gt;</span> <a class="breadcrumb-active" href="/company/privacy-policy/" target="_self">Privacy Policy</a><div class="clear"></div>					</nav>
					<div class="clear"></div>
				</div>
			</div>
			
		</header>
		<div class="content-between-header-footer">		

<main class="container">
	<h1>Privacy Commitment</h1>
<p><span>PAREXEL will collect information through its websites that can identify you (if provided by you), such as your name, address, phone number, e-mail address, company name and position. PAREXEL may use this information to respond to your requests for information, products or services. PAREXEL may also collect information that will usually not allow us to identify you, such as information gathered through "cookies" (see below).</span></p>
<p><span>When you contact PAREXEL via its website to request or to access information, you are asked to provide your personal information. By providing your personal information to PAREXEL via its website, you agree to the terms of this Privacy Policy and to receive communications from PAREXEL.</span></p>
<p><span>The information you provide to us will be available to PAREXEL, its subsidiaries and third parties working with or on behalf of PAREXEL. Access to your information and the equipment processing it, is at all times restricted to appropriate staff. Except as set forth in this Privacy Policy, PAREXEL will not trade, sell, release, share or transfer your personal information for use by any business outside the PAREXEL organization without your consent, or in a form other than what was disclosed to you at the time the information was collected, unless permitted or required by law.</span></p>
<p><span>PAREXEL reserves the right to disclose all information collected to the extent required by law or to respond to judicial process. PAREXEL may also provide any or all collected information to a third party in connection with the sale, assignment, or other transfer of the business of the particular website to which the information relates if such third party agrees to treat all such information substantially in accordance with this Privacy Policy.</span></p>
<p><span>PAREXEL takes reasonable measures to maintain the confidentiality of your personal information regardless of the country where such information is stored or transferred to.</span></p>
<h2>U.S.-EU and U.S.-Swiss Safe Harbor Certification</h2>
<p><span>PAREXEL International Corporation (PAREXEL) complies with the U.S.-EU and U.S.-Swiss. Safe Harbor Frameworks in connection with the collection, use, and retention of personal information from European Union member countries and Switzerland to its affiliates in the United States. PAREXEL has certified that it adheres to the Safe Harbor Privacy Principles of Notice, Choice, Onward Transfer, Security, Data Integrity, Access, and Enforcement, for personal data pertaining to clinical research participants, patients, human resources, customers and suppliers, in any format. You can learn more about the Safe Harbor principles and PAREXEL’s additional obligations under the Safe Harbor Certification Program by going to the U.S. Department of Commerce's Safe Harbor website at: www.export.gov/safeharbor/. You can also view PAREXEL's Safe Harbor certification information through that site. If you have questions about PAREXEL's Safe Harbor practices under the U.S.-E.U. or U.S.-Swiss frameworks, or believe that your information has been mismanaged, you can contact PAREXEL’S U.S. Privacy Officer by writing to us at:&nbsp; PAREXEL International Corporation, 195 West Street, Waltham, MA 02451, or by using the Contact Us link on this website.</span></p>
<p class="p1">**Please be advised that in response to the European Court of Justice’s recent decision to invalidate the Safe Harbor agreement between the European Commission and the US Department of Commerce, PAREXEL is committed to the confidentiality, integrity and availability of personal information we process and is putting in place other mechanisms to ensure a compliant transfer of personal information from European Union member countries to the U.S.</p>
<h2>Cookies and Other Web Tracking Techniques And How We Use Them</h2>
<p>When you use our sites, PAREXEL will assign cookie files (“cookies”) to you, which are a small amount of information we send to your web browser. Cookies enable the computers operating our websites to differentiate between visitors and to track the patterns of activities engaged in by different visitors. By tracking such activities, the computers operating our websites can recognize a visitor and customize certain features for that visitor. We may also use aggregated, non-identifiable information regarding persons who visit our site in order to learn more about the use of the site and how we can improve it.</p>
<p>You may be able to modify your browser preferences to accept all cookies, to be notified when a cookie is set, or to reject all cookies. If you choose not to accept cookies, you may not be able to use those functions of the websites that require registration.</p>
<p>We may also receive IP addresses in the normal course of the operation of our website. An IP address is a number assigned to you by your Internet service provider so you can access the Internet. Although we do receive IP addresses, we do not use them to identify you personally or disclose them to others.</p>
<p>This website uses Google Analytics, a web analytics service provided by Google, Inc. ("Google") and ShareThis, a web analytics service provided by ShareThis, Inc. (“ShareThis”). Both tools use cookies to help the web team analyze how users use the site. The information generated by the cookies about your use of the website (including your IP address) will be transmitted to and stored by Google and ShareThis under their privacy policies:</p>
<p><br>ShareThis:&nbsp;<a href="http://sharethis.com/privacy" target="_blank">http://sharethis.com/privacy</a><br>Google: &nbsp;<a href="http://www.google.com/intl/en/analytics/privacyoverview.html" target="_blank">http://www.google.com/intl/en/analytics/privacyoverview.html</a></p>
<p><span>You may refuse the use of cookies by selecting the appropriate settings on your browser, however, please note that if you do this you may not be able to use the full functionality of this website. By using this website, you consent to the processing of your information by Google and ShareThis in the manner and for the purposes set out above.</span></p>
<h2>Information Security</h2>
<p><span>PAREXEL maintains a reasonable level of physical, electronic and managerial procedures in order to protect the information that it collects from its website. This includes maintaining computer equipment, networks, programs and documentation to a common standard and restricting access to equipment and information to appropriate staff.</span></p>
<h2>Children's Privacy</h2>
<p><span>PAREXEL does not collect or maintain information at its websites from those it knows are under 13 years of age, and no parts of its websites are structured to attract anyone under the age of 13.</span></p>
<h2>Links to Other Websites</h2>
<p><span>Our websites may contain links to other websites. Please keep in mind when you access websites operated by other parties, whether through links on our websites or otherwise, that we do not control what happens on those websites. You should always check the privacy policy of the website you are visiting in order to be sure you know how the operator of that website will collect information from you and what the operator of that website will do with the information.</span></p>
<h2>Change Notification</h2>
<p><span>As we provide more services on our websites and as privacy laws and regulations evolve, it may be necessary to revise or update our Privacy Policy without notice. You can determine if this Privacy Policy has been revised since your last visit by referring to the "last updated" legend at the bottom of this page. &nbsp;Your use of our website constitutes your acceptance of the terms of the revised Privacy Policy, and you should therefore review the Privacy Policy regularly to ensure that you are aware of its terms. &nbsp;Please print, save, and retain a copy of the Privacy Policy (and of any revised version) for your records.</span></p>
<h2>Inquiries, Complaints and Information Corrections</h2>
<p><span>To be removed from our contact lists, or to make a complaint or submit an inquiry, please write to PAREXEL at the following address:</span></p>
<p><span>PAREXEL International Corporation<br>Att: Webmaster<br>195 West Street<br>Waltham, MA 02451<br>This Privacy Policy was last updated on November 2015.</span></p></main>

<section id="related-content-container">
		<div class="clear"></div>
</section>
<section id="relationship_bottom_2" class="wrapper" style="display:none">
		<section class="stage_content">
		<div class="bottom_1">
			<h2>Make  part of your solution</h2>
			<p></p>
					</div>
		<div class="clear"></div>
		<div class="bottom_2">
			<h3 style="font-weight:bold;font-size:1.25em;"></h3>
			<h3>Products and Services</h3>
			<p></p>
		</div>
		<div class="bottom_3">
			<ul class="content_bottom_nav"><li class="alpha"><a href="/company/management-team/" target="_self" class="">Management Team</a></li><li class=""><a href="/company/news-events/" target="_self" class="">News &amp; Events</a></li><li class=""><a href="/company/locations-and-offices/" target="_self" class="">Find an Office</a></li><li class="omega"><a href="http://investor.parexel.com/" target="_blank" class="">Investors</a></li></ul><ul class="content_bottom_nav"><li class="alpha"><a href="/company/careers/" target="_self" class="">Careers</a></li><li class=""><a href="/company/volunteer/" target="_self" class="">Volunteer</a></li><li class=""><a href="/company/sustainability/" target="_self" class="">Sustainability</a></li><li class="omega"><a href="/company/code-conduct/" target="_self" class="">Code of Conduct</a></li></ul><ul class="content_bottom_nav"><li class="alpha"><a href="/company/eclinical-innovation/" target="_self" class="">eClinical Innovation</a></li><li class=""><a href="/company/purchasing/" target="_self" class="">Purchasing</a></li><li class="omega"><a href="/company/contact/" target="_self" class="">Contact Us</a></li></ul>		</div>
	</section>
	<div class="clear"></div>
</section>
			
			<div class="clear"></div>
			</div> <!-- .content-between-header-footer -->
			<footer>
				<div id="linkedin">
					<div class="container">
						<div>
							<p class="section_header">Linkedin Updates</p>
							<a class="linkedin-link" href="https://www.linkedin.com/company/parexel">View Profile</a>
						</div>
						<div class="linkedin_content">
							
<div class="ccm-jereme-tweetcrete">
  <div class="ccm-jereme-tweetcrete-timeline">
      </div>
  
  
  <div class="ccm-jereme-tweetcrete-timeline">
    <ul>
                        <li class="alpha">
                                    <div class="ccm-jereme-tweet-text" style="height: 72px;">Read about <a href="http://twitter.com/PAREXEL" target="_blank">@PAREXEL</a> in <a href="http://twitter.com/CNNMoney" target="_blank">@CNNMoney</a> article on reinventing work <a href="http://twitter.com/flexjobs" target="_blank">@flexjobs</a> <a href="http://twitter.com/jjsahadi" target="_blank">@jjsahadi</a> <a href="https://t.co/bRH1U6FTlY" target="_blank">https://t.co/bRH1U6FTlY</a>  <a href="https://twitter.com/search?q=%23FJTop100&amp;src=tweetcrete" target="_blank">#FJTop100</a>                          </div>
            <div style="clear:both;"></div>
          </li>
                  <li>
                                    <div class="ccm-jereme-tweet-text" style="height: 72px;">The key to drug development. Read <a href="http://twitter.com/PAREXEL" target="_blank">@PAREXEL</a>’s expanded <a href="https://twitter.com/search?q=%23genomic&amp;src=tweetcrete" target="_blank">#genomic</a> research services. <a href="https://t.co/UmFFvdTZyF" target="_blank">https://t.co/UmFFvdTZyF</a> <a href="https://twitter.com/search?q=%23personalizedmedicine&amp;src=tweetcrete" target="_blank">#personalizedmedicine</a>                          </div>
            <div style="clear:both;"></div>
          </li>
                  <li class="omega">
                                    <div class="ccm-jereme-tweet-text" style="height: 72px;">Explore common <a href="https://twitter.com/search?q=%23spirometry&amp;src=tweetcrete" target="_blank">#spirometry</a> mistakes w/ <a href="http://twitter.com/PAREXEL" target="_blank">@PAREXEL</a> experts in latest <a href="http://twitter.com/Clin_Trials" target="_blank">@Clin_Trials</a>  article <a href="https://t.co/4rpYnlhoDr." target="_blank">https://t.co/4rpYnlhoDr.</a>                          </div>
            <div style="clear:both;"></div>
          </li>
                  </ul>
  </div>
</div>  
							 <div class="clear"></div>
						</div>
						<div class="clear"></div>
					</div>
				</div>
				<div class="clear"></div>
				<div id="top_footer_section">
					<div class="container">
						<div id="footer_left" class="footer-bucket">
							<p class="footer_header">CAREERS AT PAREXEL<sup>®</sup></p>
<p><span class="footer_regular">If you are inspired to make a difference<br> in the world, we can help you make it possible.</span><br> <a title="Opportunities" href="https://jobs.parexel.com">Search positions worldwide</a></p>
<p class="footer_regular"><strong>PAREXEL International Corp.</strong><br><strong>+1 781 487 9900</strong><br><strong>195 West Street</strong><br><strong>Waltham, MA 02451&nbsp;</strong></p>						</div>
						<div id="footer_middle" class="footer-bucket">
							<ul class="footer_list nav">
<li class="alpha"><a title="Company" href="/company/" class="active">ABOUT PAREXEL<sup>®</sup></a></li>
<li><a title="News &amp; Events" href="/company/news-events/">NEWS &amp; EVENTS</a></li>
<li><a title="Investors" href="http://investor.parexel.com">INVESTORS</a></li>
<li><a title="Volunteer" href="/company/volunteer/">VOLUNTEER</a></li>
<li><a title="Contact Us" href="/company/contact/">CONTACT</a></li>
<li class="omega"><a title="Customer Care" href="http://support.perceptive.com/support/" target="_blank">CLIENT LOGIN</a></li>
</ul>						</div>
						<div id="footer_right" class="footer-bucket">
							<ul class="footer_list nav">
<li class="alpha"><a title="Liquent®" href="/liquent/">LIQUENT<sup>®</sup></a></li>
<li><a title="Clinical Trial Investigator Sign-up" href="/company/investigator-signup/">CLINICAL TRIAL&nbsp;INVESTIGATOR</a></li>
<li><a title="Site Map" href="/site-map/">SITE MAP</a></li>
<li><a title="Terms" href="/company/terms-service/">TERMS OF SERVICE</a></li>
<li class="omega"><a title="Privacy Policy" href="/company/privacy-policy/">PRIVACY POLICY</a></li>
</ul>						</div>
						<div class="clear"></div>
					</div>
				</div>		
			 	<div class="clear"></div>
				<div id="bottom_footer_section">
					<div class="container">
						<p class="copyright">Copyright ©2000-2016 PAREXEL International Corporation.&nbsp;</p>					</div>
				</div>
			</footer>
		</div><!-- #page -->

		<!-- remodal -->
			
			<!-- Call the modal with data-remodal-id="modal" -->
			<a data-remodal-target="modal" style="display"></a>
		<!-- end remodal div -->
		
			<!-- JAVASCRIPT LIBRARY INCLUDES -->
	<script type="text/javascript" src="/themes/parexel-responsive/js/lib/selectivizr-min.js"></script>
	<script type="text/javascript" src="/themes/parexel-responsive/js/lib/modernizr.js"></script>

	<script type="text/javascript" src="/remodal/dist/remodal.js"></script>
	<script type="text/javascript" src="/fancybox/fancybox.js"></script>
	<script type="text/javascript" src="/fancybox/fancybox.pack.js"></script>

	<!-- JAVASCRIPT CUSTOM INCLUDES -->
	<script type="text/javascript" src="/themes/parexel-responsive/js/custom/global.js"></script>
	<script type="text/javascript" src="/themes/parexel-responsive/js/custom/blog.js"></script>
	<script type="text/javascript" src="/themes/parexel-responsive/js/custom/media_query.js"></script>
	<script type="text/javascript" src="/themes/parexel-responsive/js/custom/mega-menu.js"></script>


	<!--[if lte IE 9]>
		<script type="text/javascript" src="/themes/parexel-responsive/js/lib/html5shiv.js"></script>
	<![endif]-->	

<div class="remodal-overlay remodal-is-closed" style="display: none;"></div><div class="remodal-wrapper remodal-is-closed" style="display: none;"><div class="remodal remodal-is-initialized remodal-is-closed" data-remodal-id="modal" tabindex="-1">
				<button data-remodal-action="close" class="remodal-close"></button>
				<div class="remodal-content">
					
				</div>
				<div class="remodal-href" style="display:none;"></div>
			</div></div></body></html>